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ABSTRACT
The present investigation examined the cardiovascular
and metabolic effects of various types of prostaglandin
(PGA, PGB, PGE and PGF) and arachidonic acid in
snakehead fish Ophiocephalus maculatus Lacepede. Also the
distribution of prostaglandin E in different tissues of
snakehead was demonstrated. In order to verify the possible
participation of endogenous prostaglandins in the physiology
of'snakehead, the prostaglandins synthetase inhibitors,
indomethacin and aspirin, were applied to the fish.
Using silicic acid column chromatographic and colorimetric
techniques, the presence of prostaglandin E in various tissues
including gill, urinary bladder, kidney, heart, spleen, muscle,
liver and gastrointestinal tract was demonstracted.
Intravenous injection of prostaglandins (PGA1, PGB1 and
PGE1) produced hypotensive or hypertensive effects whereas
PGF1 and arachidonic acid did not alter arterial blood
pressure. Furthermore, indomethacin significantly lowered basal
blood pressure.
Plasma chemistry was studied after intraperitoneal
injection of PGs. All prostaglandins uniformly produced
hyperglycemia. No change in liver glycogen content occurred
after PGs injection except that arachidonic acid decreased
glycogen level. However, only PGE1 and PGF1 significantly
lowered plasma protein and PGA1 and PGB1 could not change this
plasma parameter. Decrease of plasma free fatty acid and
lipid was shown after injection of PGE1. No change in K+
and Na+ levels was observed.
Moreover, the results of in vitro studies in liver cell
showed that PGa have no effect on glutamate oxaloacetate
transaminase, glutamate pyruvate transaminase and glucose-6-
phosphatase activities.Also PGs did not exert antilipolytic
effect on fat cell except PGB1 increased glycerol production
in this preparation.
Aspirin treatment decreased plasma protein and Na+
levels while no observable effects were found in hematocrit,
plasma osmolarity, glucose, free fatty acid, lipid, Cl--, Mg++,
Ca++ and K+ levels.
The significance of these findings in relation to
comparative physiology was discussed.
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Prostaglandins (PGs) are unsaturated fatty acids
with twenty carbon atomst a cyclopentane ring and two
aliphatic side chains one of the side chains bears a
terminal carboxyl group. There are various types of
naturally-occurring prostaglandins classically categorized
into four series: E, F, A. and B. Classification is based
upon the type and location of the functional groups, and
the degree of unsaturation (Curtis-Prior, 1976d) (for details
see Chapter 2, pp. 12-16).
Prostaglandins have been known to be widely
distributed in nearly all tissues of various mammals
(Karim t al., 1968 Karim et al., i.967. but only
little information is available on lower animals. A wide.
spread distribution of Prostaglandins in the animal kingdom
was reported by Nomura and Ogata (1975) (see also
Literature Review: pp.26-32). Nomura et al. (1973)
isolated prostaglandin-like substances from the -testis -of
teleosts and the gastrointestinal tract of the shark.
In the latter case, the material has been chromatographically
identified as PGE2 (Ogata and Nomura, 1974).
In mammals t the biosynthesis of prostaglandins from
essential fatty acids, dihomo- -linolenic acid and
arachidonic acid has been well documented (Bergstrom et al.9
19611). Recently, similar studies on PG biosynthesis in
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several lower animals have been published. Christ and von Dorp
(1964) investigated the comparative aspects of prostaglandin
biosynthesis in animal tissues. Ogata and colleagues (1978)
also showed the existence of prostaglandin synthetase
activity in the tissues of fish and marine invertebrates.
Among various types of prostaglandins, physiological
studies on prostaglandin E is mostly studied, therefore
the biological actions of E type prostaglandin is well
known especially in mammals. The first examined
physiological property of prostaglandin was based on the
observation that extracts of mammalian seminal fluid when
injected into animals characteristically lowered the blood
pressure of many species including rabbit, cat and dog
(von Euler, 1935a Goldblatt, 1935). Since the separation
and identification of many different naturally occurring
PGs, these compounds became available for the investigation
of their cardiovascular-actions. E series prostaglandins
(PGE1, PGE2, PGE3) uniformly lower arterial blood pressure
in all the laboratory animals studied. These animals included
the dog (Bergstrom et, al 1964 Sanbar et al., 1967
Chapple et al., 1980), rat (Weiner and•Kaley,1969
Ten Berg et al., 1980 Kondon et al., 1980), cat (Horton
and Main, 1963), rabbit (Horton and Main, 1963), guinea-pig
(Berta et al., 1967), goose (Grande and Prigge, 1972).
and chicken (Horton and Main,1967), but there are very
few reports on lower vertebrates (carp: Peyraud-Waitzenegger
et al., 1975). Hence, the vascular effects of prostaglandin
3
in lower vertebrates are especially interesting from a
comparative point of view. The depressor activity of PGE
has been related to vasorelaxation and decrease in vascular
resistance (Saunders and Moser,1972 Chapple et l., 1980).
PGE has been shown to bring about tachycardia (Grande and
Prigg, 1972 Peyraud-Waitzenegger et al. p 19759-.Hoffman
and Schmid, 1979 Hornych et al., 1979) and increase
cardiac output (Weeks and Wingerson, 1964 chapple et al.,
1980). PGA also elicits similar cardiovascular effects
as PGE (Lee et a1., 1965 Westura et al., 1970 Jones, 1972).
However, effects of PGF on cardiovascular system are
controversial. Karim et a1. (1969) reported the
cardiovascular effects of PGF2,infusion in. human volunteers.
Continuous infusion of 0.01 to 2.0 pg/kg/min PGFfor sixty
minutes did not have any effect on blood pressure and heart
rate. However, other studies showed the contrary, PGF2
in doses up to 20 )ug/kg was reported to be enough to increase
blood pressure of the rat and dog (Ducharme t al., 1968
Saunders and Moser, 1972 Shehadeh et al., 1969).
Therefore, PGF2 evoked species-dependent vascular responses.
Moreover, Schauinen and Houvenaghel (1978) reported a dose
dependent response to intra-arterial PGF2 infusion in the
pig. At higher doses (3-100 pg/min) a direct dose-
dependent decrease in mesenteric blood flow occurred whereas
lower doses (0.03-1 yg/min) induced a delayed increase in
mesenteric blood flow. A decrease of vascular resistance
and positive chronotropic effect of prostaglandin F was
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reported (Schuwen et al., 1979 Kushiku and Furukawa,,
1979 Saunders and Moser,, 1972). However,, little information
regarding the cardiovascular effect of PGB has been
published. A PGB1-induced decrease in perfusion rate in
the perfused kidney of the frog was observed.(Chiu and Leung,
unpublished). In addition, a decrease of blood pressure
by PGB was demonstrated by Jones (1972).
The. first observation of the effect of prostaglandins
on lipid metabolism was made by Steinberg et al. (1963).
PGE1 depressed basal and. hormone stimulated lipolysis in
adipose tissue of rat (Steinberg et al., 1963) and man
(Carlson, 1965). The relative potencies of several PGs
in blocking epinephrine-induced lipolysis were compared
(Steinberg et al,, 1964). PGEZ was more potent than PGEZ
PGE3 was ineffective except at a very high concentration
(16.6 1ig/ml). E group prostaglandins were more potent than
F group prostaglandins with respect to lipolysis. In vim,
PGEZ infusion decrease plasma free fatty acids (FFA) in the
dog (Sanbar et l., 1967). However, many studies have
reported that prostaglandins stimulated lipolysis. PGA1
infusion (0.25 ig/kg/min) in anesthetized dog induced increase
of plasma FFA (Sacca t al., 1973) and PGEZ caused an increase
of plasma glycerol and FFA levels in geese and man (Grande
and Prigge, 1972 Bergstrom et al, 1965). Therefore the
contradictory effects of prostaglandins on lipid metabolism
may be due to species specificity, the doses employed or
different experimental conditions.
Bergstrom and coworkers (1966) tried to clarify
whether the lipolytic responses may be dose dependent.
They found that the smallest dose of 0,2 jigkgmin PGE
produced a reproducible increase in venous plasma FFA level.
Plasma glycerol level showed the same type of response but
the rise was not statistically significant. At higher
doses (0,4, 0,8 and 1,6 jagkgmin), a dose-dependent
decrease of plasma FFA and glycerol levels was observed.
The low dose (0,2 jagkgmin) effect on elevation of plasma
FFA level was abolished by a sympathetic ganglionic
blocking agent, whereas the same drug was without influence
on the high dose effects. This suggests that PGE exerts
not only a direct inhibitory effect on FFA mobilization
from adipose tissue, but may be in addition, at low infusion
rates, enhances lipid mobilization due to a stimulation of
sympathetic nervous activity. Moreover, Sham and Ramwell
(1968) suggested a role for prostaglandins in the
regulation of basal or hormone stimulated lipolysis,
Christ and Nugtell (1970) demonstrated the release of
arachidonic acid and from rat epididymal adipose tissue
during lipolysis. It has been suggested that PGs are
involved in maintenance of adipose tissue hompstasis by
means of a physiological negative feed-back inhibition
mechanism.
Besides their actions on lipid metabolism,
prostaglandins also exhibit profound influence on glucose
metabolism, PGA and PGE produced hyperglycemia in animals
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so far studied (dog: Bergstrom et al. 1966 and Sacca
et al.f 1973 goose: Grande and Prigge, 1972 rat: Berti
et al., 1965). Since catecholamines have been shown to
induce hyperglycemia in vertebrates (Gordon et al., 1977)
in order to clarify the action of PGs and their relationship
with catecholamines on glucose metabolism' studies on the
effects of PG on the liver in vitro were undertaken.
Since hyperglycemia was induced by using a continuous
infusion of PGE in rat and guinea pig but adrenalectomized
animals failed to show the same response led Berti et al.
(1965) to the conclusion that this effect is mediated
through catecholamines. Furthermore, Bohle and May (1967)
found a decrease in glycogen levels in liver slices incubated
with PGE1I Therefore, it seems that the results of
Berti et al..(1965) and Bo-qhle and May (1967) are apparently
in contradiction. In addition, Lemberg et al,(1971)
found that the actions of norepinephrine (induced hyperglycemia)
and PGE1 take place at different sites in the liver cell.
Norepinephrine acts on a f3-receptor of the hepatic cell
membrane because its effect could be blocked by a `3-blocker.
However, Wilson and Levine (1970) demonstrated a PGE1
induced-decrease in labeled glucose incorporation in the
perfused rat liver. More evidence shows that PGE
significantly increases glycogen breakdown in low glycogen
liver (Wilson and Hankewych, 1973). Curnow and Nuttall (1972)
observed that PGE1 decrease hepatic glycogen synthetase
without altering glycogen concentration. This change is
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compatible with increased hepatic cAMP and suggGated
possible direct effects on hepatic glycogen levels. However,
Levine (1978) showed no effect of PGE1 on hepatic
glycogenolysis. Despite the variable effects of PGs on
glucose metabolism, PGE1 has definitely been reported to
cause hyperglycemia or to inhibit glucose metabolism in
the liver.
Among the various reports on physiological studies
of prostaglandins, only the effects of E--type prostaglandins
have been completely surveyed. On. the.other hand, the effects
of prostaglandin A and F are less studied and investigations
on prostaglandin B is scarce. A more complete study of the
physiological effects of these four types of prostaglandin
is especially interesting since most species employed in
the examination of the physiological role of prostaglandin
are mainly mammals or higher vertebrates. Therefore, the
present study will focus on the effects of PGs in a lower
vertebrates. The freshwater teleost, Ophiocephalus
maculatus Lacepede (Snakehead), was chosen as the
experimental animal in the present study. This is because
some aspects of the physiology of the snakehead has been
established in our laboratory (Tong, 1980 Woo and Cheung,
1980 Woo et al. 1980 Woo and Tong, 1981 and the animals
are also available in Hong Kong throughout the year.
Moreover, because of easy surgical access as well as
resistance to experimental manipulations, snakeheads are
excellent subjects in physiological investigation.
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The present study attempts to examine the
cardiovascular and metabolic effects of prostaglandins
(PGE1, PGF1 o, PGA 1 and PGB 1) in Ophio c epha lus macul atu s.
The examination is divided into four sections:-
(1) Distribution of prostaglandins in various tissues
(2) A survey of the effect of aspirin (a prostaglandin
biosynthesis inhibitor) on metabolism and
osmoregulation
(3) Cardiovascular effects of prostaglandins
(4) In vivo and in vitro studies on metabolic effects
of prostaglandins.
9CHAPTER II LITERATURE REVIEW
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CHAPTER II: LITERATURE REVIEW
(I HISTORY, NOMENC LATUREV BIOSYNTHESIS AND METABOLISM
OF PROSTAGLANDINS
(1) History
The first definite reference to the existence of what
is now known as prostaglandins was made by Kurzrok and Lieb
in 1930. They showed that fresh human semen could either
inhibit or stimulate the motility of-the human uterus
in vivo. A few years after the studies of Kurzrok and
Lieb, von Euler and Goldblatt independently observed and
studied the marked smooth muscle stimulating activity of
human seminal fluid (Euler, 1934, 1935a, b Goldblatt,
1933, 1935). Von Euler (1934) prepared lipid soluble acid
extracts of human seminal fluid and that of monkey, sheep
and goat, and observed their smooth muscle stimulating and
blood pressure lowering properties. Because of the source of
his extracts-.mammalian accessory genital glands-von Euler
coined the term 'prostaglandin' for the active factor
present. It was not until 1960, and with a US $100,-000--grant
from The Upjohn Company, that the first pure prostaglandin
compounds were isolated by Bergstrom and Sjovall (1960).
Prostaglandin had been shown to be not juat. a single substance
but a family of several chemically related compounds derived
from the hypothetical prostanoic acid (Fig.1, pp. 11).





10 2 014 16 18
11 115 1713
Fig. 1 Structural formula of the hypothetical
prostanoia acid.
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compounds available to a large number of investigators.
(2) Nomenclature
The term prostaglandin is a misnomer first defined
by von Euler because these compounds are found not only
in seminal fluid but also in nearly all tissues of
vertebrates (Nomura and Ogata, 1976 Ogata and Nomura, 1975
Curtis-Prior et alot 1978) as well as invertebrates
(Nomura and Ogata, 1975 Weinheimer and Spraggins, 1969).
All of the prostaglandins have in common the prostanoic
acid skeleton (Fig. 1 p. 11). The primary prostaglandins
are divided into four types based on the functional groups
in the cyclopentane ring: E type (11-hydroxyketones),
F type (9, 11-diols), A type (10, 11-unsaturated ketones)
and B type (8, 13.-unsaturated ketones) (Fig. 2, p. 13).
The natural prostaglandins are also grouped into the mono-,
bis-, or triunsaturated classes according to the number of
carbon-carbon double bonds in the two aliphatic side chains
of parent E-type prostaglandin. This class designation
appears as a subscript-number in the names of prostaglandins.
The location of the double bonds is the same in all
prostaglandins. In mono-unsaturated prostaglandins, the
location of C-C double bond is between carbon 13-14. The
bisunsaturated class has two double bonds between carbon
13-14 and 5-6. Moreover, the locations of unsaturation are
between carbon 13-14, 5-6 and 17-18 in triunsaturated class.


















present the possibility of stereoisomers. However, only
one isomer of each type has so far been isolated (Samuelsson,
1973 Ogata Nomura, 1 975 Nomura and Ogata, 1975). An
alpha/beta system is employed to define the stereochemistry
of functions on the cyclopentane ring. Alpha substituents
are orientated on the same, side of the ring as the aliphatic
side chain bearing the carboxyl group whereas beta substituents
are orientated on the side of the ring bearing the alkyl side
chain. However, only alpha substituent is found in naturally
occurring rostaelandins_
(3) Other related compounds of prostaglandins
Studies on the mechanism of the formation of
prostaglandins from polyunsaturated fatty acids led to the
finding of many intermediates in the biosynthesis of
prostaglandins (Samuelsson, 1972). Jones (1970) and Horton
et a1. (1971) reported the enzymatic conversion of PGA to
PGB and led to the discovery of a new prostaglandin
(PGC (Fig. 3. p. 15)), A single shift of the 10, 11
double bond in PGA produces the 11, 12 double-bonded isomer
(PGC) and the PGC will rapidly be converted to PGB under
mildly alkaline condition (Polet and Levine, 1975). 'Since
PGCs are unstable compounds, they exist in small amounts in
the tissues. Moreover, another type of prostaglandin, PGD,
contains a hydroxyl group at carbon 9 and a ketone at carbon
11 (Fig. 6, p. 21) but the two aliphatic side chains are












Fig. 3 Conversion of PGA2 to PGB2
via an intermediate PGC2 by
PGA2 isomerase
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research has led to the identification of three other
types of compound (see• Horrobin, 1978)
(a) Prostaglandin endoperoxides
These compounds possess two oxygen atoms derived
from the same oxygen molecule linking. the 9 and 11
position of the pentane ring. Endoperoxides include
PGH and PGG. PGH has side chains similar to those of
the classical PGs, while PGG has an extra oxygen
between the 15 carbon and its hydroxyl group (Fig. 4,
P 17 ) •
(b) Thromboxanes
Thromboxanes are derived from the endoperoxides
and have two oxygen atoms inserted into the carbon
ring. There are two groups of thromboxane:
(i) thromboxane A (TXA) and (ii) thromboxane B (TXB)
(Fig. 4, P. 17).
(c) Prostacyclin
An oxygen bridge linking the carbon 9 of the ring
to the carbon 6 of the side chain is found in this type
of compound (Fig. 5, p. 1.8). In the past, PGX is
used to denote the abbreviation of prostacyclin.
These compounds have been renamed and are now called
prostaglandin I to conform to the prostaglandin
nomenclature.
(4)Biosynthesis of Prostaglandin


















Fig. 5 Structural formula of PGI2.
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biosynthesis of prostaglandin and this leads to the new
finding of many intermediates and products. Bergstr6m et al.
(19614) and Van Dorp et al. '1964) found that homogenates of
sheep seminal vesicles could convert enzymatically arachidonic
acid to prostaglandin E2• Moreover, formation of the 1 series
of prostaglandins from dihomo-gamma-linolenic acid has been
demonstrated (Beerthuis et a1., 1968). This suggests that
dietary fatty acids, arachidonic acid and dihomo-gamma--linolenic
acid may be the precursors of prostaglandins in mammalian
tissues and organs. Furthermore, the enzyme complex of
biosynthesis of prostaglandins was called prostaglandin
synthetase. It is generally considered to be membrane-bound
(Curtis-Prior, 1976).
Early studies on the mechanism of the formation of
prostaglandin from polyunsaturated fatty acids showed that
oxygen atoms of the keto group and the hydroxyl group in the
five-membered ring of PGE1 originated in the same molecule
of oxygen (Samuelsson, 1965). On the basis of this result
and other considerations, it was proposed that an endoperoxide
structure is formed as an intermediate in the biosynthesis of
prostaglandins (Samuelsson, 1965). Later in 1973, the isolation,
characterization and examination of biological activity of
two endoperoxide •intermediates, PGG and PGH has been successfully
demonstrated (Hamberg and Samuelsson, 1973 Nugteren and
Hazelhof, 1973). PGH has now been shown to be a common
precursor of PGE, PGF, PGD, PGI and thromboxane (for details
see Schneider, 1976 Samuelsson, 1978). In addition,
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PGA1, PGA2, and their 19-hydroxy analogues as found in
kidney medulla, semen and other tissues are largely enzymatic
products (Attallah et al ., 1974). Furthermore, PGC has been
shown to result from the action of an isomerase present in
blood plasma (Jones et al., 1972), and this unstable
prostaglandin will rapidly be converted into PGB. An outline
of the biosynthetic pathway of 2 series of prostaglandins
and related compounds from arachidonic acid is shown in
Fig. 6( p. 21).
(5) Catabolism of Prostaglandins
Prostaglandins are rapidly catabolised by a variety of
animal tissues to products possessing reduced biological
activity. Lung (Ferreira and Vane, 1967 Piper et l., 1970)9
liver (Vane, 1969andkidney (Larsson and Anggard, 1973 ),
human placenta (Jarabak, 1972) appear to be*major sites of
prostaglandin degradation. Samuelsson and coworkers (1971)
has reviewed the metabolism of prostaglandins and found out
a number of metabolites of -prostaglandins. The most
important metabolic pathway are summarized in the following
(for details see also Curtis-Prior, 1976):
(a) Dehydrogenation of the C15 hydroxyl group by 15-hydroxy-
dehydrogenase to give 15-keto compounds.
This enzyme is widely distributed in lung homogenate
(#Anggard and Samuelsson, 1966), human placenta (Jarabak,
1972), kidney of rabbit and rat (Curtis-Prior, 1976b,c) and
lung and spleen (Anggard et al., 1971). It is probably
the main enzymes responsible for the extremely effective
Fig 6 Transformation of arachidonic acid (AA) to various prostaglandins
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destruction of the biological activity of E and F
prostaglandins by the lungs. (see also Marrazzi and
Andersen, 1970.
(b) Reduction of the C-13 double bond by PG 13-reductase
It seems probable that in many situations this
reduction follows the dehydrogenation although this is
probably not always the case (Curtis-Prior, 1976f).
(c) Beta oxidation
This is the non-specific removal of 2 carbon fragment
from the carboxylic end of the molecule. This oxidation
occurs as in all other fatty acid metabolism. Removal
of one 2-carbon fragment gives a dinor derivative while
removal of two 2-carbon fragments give a tetranor
derivative (Samuelsson et al., 1971).
(d) Omega hydroxylation at C-19 or C-20
A hydroxyl group is inserted into carbon 19 or 20.
This omega-hydroxyl metabolite may undergo beta oxidation
(McDonald-Gibson et l., 1973).
(e) Omega oxidation of alkyl side chain
The omega hydroxyl group is converted into.a carboxyl
group. Metabolism of the E prostaglandins by these five
stages gives 7 -hydroxyl-5, 11 -diketotetranorprosta-1,
16-dioic acid, the main urinary metabolite in man
(Hamberg and Samuelsson, 1971). Similar pathways
metabolize the F Prostaglandins (Powell, 1980).
However, there are probably many differences in
metabolism between tissues and between species and much
more work is required in this field.
(f) Conversion of thromboxane A to thromboxane B
Thromboxane A is a highly unstable compound with a
half life of around 30 seconds in buffer solution and
it is probably non-enzymatically converted to
thromboxane B, a much more stable and relatively inert
substance (Horrobin, 1978).
(g) Conversion of to 6-keto PGP
PGX is also unstable and is converted partly
enzymatically to 6-keto PGF (Sun and Tayler, 1978;
Pace-Asciak ejb al., 1977)
(h) Prostaglandin A-isomerase
Relatively little work has been carried out on the
metabolism of prostaglandins of the A series. Whereas
they are not inactivated by passing through the lungs.
(Horton and Jones, 1969), they are metabolized by an
enzyme in plasma (Jones, 1970) This enzyme is called
PGA-isomerase which catalyses PGA to PGC and finally to
PGB (Fig. 3, p. 15)• The details have been mentioned
earlier on p. 14•
The catabolisra of prostaglandin usually does not
follow a definite sequence of pathway, therefore, for
example, dehydrogenation of the C15 hydroxyl group may
precede reduction of the C-13 double bond or vice versa.
Moreover, the metabolism of prostaglandins may not
occur in all of these pathways and they may be
metabolized by only one or two of these enzyme systems
In addition, most of the metabolites of PGs are
excreted in the urine (Hamberg and Samuelsson, 1970
A summary of the destructive reactions occurred on
PGF, as an example of catabolism of prostaglandin
is outlined in Fig. 7( P 25)•
(6) Interconversion of Prostaglandins
PGs often can be converted to each other, sometimes
by enzymatic or non-enzymatic reactions. The most important
and frequently occurred interconversion are the followings:
(a) Conversion between PGE and PGF
This conversion is catalyzed by an NADPH-dependent
9-keto-reductase This reaction is potentially
reversible (Lee and Levine, 1970
(b) Formation of PGA from PGE
Conversion of PGE to PGA by loss of water from the
ring may take place enzymatically but may also occur
non-enzymatically particularly during Isolation
procedures PGAs are relatively resistant to degradation
by the lungs and so could act as circulating hormones
(Horton and Jones, 199)
Fig. 7 Summary of the dogradative reactions undergone
by prostaglandin F series, resulting a urinary
end-product.
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(II) DISTRIBUTION OF PROSTAGLANDINS
Although prostaglandins were first discovered in
male accessory sexual glands (Goldblatt, 1933 and 1935
von Euler, 1934), virtually, prostaglandins are widely
distributed in various tissues and body fluids of animals
(Nomura and Ogata, 1975 Pace-Asciak and Rangaraj, 1977
Weber et l., 1979 Nomura et 1., 1973 Karim et al., 1967
Weinheimer and Spraggins, 1969 Curtis-Prior t as,, 1978).
Early studies of distribution of prostaglandins were carried
out on higher vertebrates especially in mammals (Karim et al.,
1967 Karim, 1968 Karim et al., 1967 Bergstrom et al.,
1968), but the types and quantities of prostaglandins found
in various tissues and different mammalian species vary
considerably (Table I)•
Among various tissues of mammals, semen is found to
possess largest amount of prostaglandins E2, (38500 ng/g
wet tissue: Bergstrom Samuelsson, 1962 Nomura and Ogata,
1976). Kidney also.contains large quantities of PGA2 and
PGEZ (Vance, 1973) and the gastrointestinal tract and lung
possess large amounts of PGE 2 (Nomura and Ogata, 1976
Bennett et al, (1968). However, skin, testis, brain, heart,
thymus and thyroid only contain small amounts of prostaglandin
E2 (Nomura and Ogata, 1976). Moreover, PGE 2 and PGF2-Z can be
found in most tissues, whereas the occurence of PGE1, PGE
3,
PGF1,, and PGF is less prevalent. Besides seminal and renal
PGA, haemal_- and seminal= PGB have been demonstrated but no
Table 1. Distribution of prostaglandins in Mammals.
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other tissue has been reported to contain PGA and PGB.
This may be due to the less abundance of these prostaglandins
in tissues or negligence in most studies.
Later in 1969, Weinheimer and Spraggins found that a
remarkably high concentration of prostaglandin isomers in
the gorgonian, Plexaura homomalla. This led the investigators
to realize that prostaglandins are distributed not only in
higher animals but also in lower animals. To elucidate the
occurrence and the biological significance of PGs in the
reproductive system of marine animals, Nomura et al. (1973)
had made a pioneer survey of PGs in fish testes and semen.
PGE2, PGF1( and PGF2d were shown in fish testes (Nomura et al.,
1973 Nomura and Ogata, 1976). Ogata and Nomura (1975)
reported that only E type but not F type prostaglandin are
found in the gastrointestinal tract of shark. -The distribution
of prostaglandins in tissues of fish and frog is listed
(Table 2). Gastrointestinal tract, air bladder, heart, gill and
kidney are inclined to have a higher level of prostaglandins
than other tissues (Nomura et al., 1973 Nomura and Ogata,
1976). Nevertheless, little information is available for
the distribution of PGF, PGA and PGB in fish and frog.
Prostaglandins are found also in vertebrates e.g.
sea-squirt, mussel, scallop, crayfish, blue crab, sea-anemone
and gorgonia (Table 3)* It should be noted that the gills of
invertebrates possess a large amount of prostaglandin E
(Nomura and Ogata, 1976) .
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In addition, there is a scarcity of reports on the
distribution of prostaglandins in reptiles In order to
complete a thorough survey on the distribution of
prostaglandins in the Animal Kingdom, further studies on
this aspect should be pursued
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(III) PROSTAGLANDIN BIOSYNTHESIS IN ANIMAL TISSUES
Since the ubiquitous distribution of prostaglandins
in animal tissues has been shown, it is interesting to
demonstrate the biosynthesis of prostaglandins in those
tissues. After a detailed examination of prostaglandin
biosynthesis in tissue homogenates of animals has been studied
(Christ and Van Dorp, 1972 Pace-Asciak and Rangaraj, 1977,
1977 Weber t al., 1979 Ogata et l., 1978 Herman et al.,
1978), prostaglandins are virtually found to be locally
synthesized in tissues. Prostaglandin synthetase activity
was found in almost every mammalian tissue investigated as
well as in tissues from other vertebrate and invertebrate
species.
Comparative aspects of prostaglandin biosynthesis in
animal tissues was studied by Christ and Van Dorp (1972).
Vesicular gland, kidney medulla, lung and stomach of mammals
have a high capacity of conversion of prostaglandin precursor
to PGE (Christ and Van Dorp, 1972). In birds (Cock, hen and
duck), lung, kidney,, intestine, and seminal vesicles possess
high PGE1 biosynthetic activity whereas PGF, synthetic
activity is low (Christ and Van Dorp, 1972). The activities
of PG synthesis found in birds were generally lower than those
found in similar mammalian tissues (Christ and Van Dorp, 1972).
Gill, kidney, spleen and intestine of carp, trout and tench
lung, skin and urinary bladder of frog and toad whole animal
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of horny coral, jelly fish, earthworm and housefly whole
animal and gill of lobster and mussel (Christ and Van Dorp,
1972) all can synthesize prostaglandin E1. The synthetic
activities of prostaglandins from dihomo--- -linolenic acid
in lower vertebrates and invertebrates were generally low
compared with those of tissues of higher vertebrate
(Ogata et al., 1978).
Moreover, rabbit kidney has a high capacity to produce
a spectrum of different prostaglandins (PGE2, PGF2,4.,
6-ke to-PGF1,,,,., TXB2) (Weber et al., 1979). In addition,
homogenates of rat and fetal lamb brain, lung, liver, spleen,
kidney ductus arteriosus, aorta and pulmonary artery produced
different amounts of prostaglandin E2, F2'4, D2, 6.-keto-
prostaglandin F1d and thromboxane B2 (Pace-Asciak and Rangaraj,
1977)• The main prostaglandin product in fetal lamb and rat
organs was PGE2, arterial tissue formed mostly 6-.keto-PGF2.
(Pace-Asciak and Rangaraj, 1977) whereas PGD2 and TXB2
formations in these organs were relatively low. These results
demonstrate significant differences between organs and tissues
in the relative direction of the 'prostaglandin synthesis'
enzyme complex.
Furthermore, the diversification of the prostaglandin
synthetase in' different non-mammalian tissues to form one or
several of these products has not yet been fully explored,
probably because of the difficulties encountered in the
measurement of each of these products. Another possible
reason may be that-little information is yet available on the
34
biological properties and therefore on the biological
importance of products other than the classical prostaglandins
E and F .
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(iv) PROSTAGLANDIN SYNTHETASE SYSTEM
Prostaglandin synthetase is a multiple enzyme complex
catalyzing the conversion of certain unsaturated fatty acids
into a wide array of prostaglandins and prostaglandin-like
materials. The reaction is initiated by the incorporation
of two oxygen molecules at C-11 of the unsaturated eicosanoic
acid, followed by the oxygenation at C-15 and concomitant
linkage of the carbon chain at C-8 and C-12 (Samuel3son,
1965, 1972). This intermediate is PGG (Hamberg et d1., 1974)
and the hydroperoxy group at C-15 is then converted to a
hydroxy group, and this product is found to be PGH (Hamberg
et l., 1974). Finally reduction or isomerization of PGH
gives rise to PGE or PGF.
Prostaglandin synthetase activity was first demonstrated
in sheep seminal vesicle glands and subsequently in a variety
of tissues, but tissue activities were low compared to that
of seminal vesicle glands (van Dorp t al., 1964 Bergstrom
et l., 1964 Christ and van Dorp, 1972). Moreover, the
prostaglandin synthetase activity is associated with the
microsomal fraction (Nugteren et al., 1966).
PG synthetase is found in the microsomes of bovine
vesicular gland, it contains two fractions (Fraction I and
Fraction II) after ultracentrifugation. Fraction I is PG
endoperoxide synthetase, which is responsible for the
formation of PG endoperoxide (PG intermediate) from PG
36
precursor (Yamamoto et al., 1977.). Fraction II can convert
PG endoperoxide to prostaglandin and it is called PG
endoperoxide E-isomerase (Yamamoto et al., 1977) (For
details see also Yamamoto et al. 1977 Pong and Levine,
1977)•
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(v) EXTRACTIONS SEPARATION AND QUANTITATION OF PROSTAGLANDINS
After the first discovery of the acidic, lipid-soluble,
smooth muscle stimulating compounds (prostaglandins) in
seminal fluid (Goldblatt, 1933 von Euler, 1934, 1935),
there was a long period of inactive pursuit on the properties
of these compounds. This may probably be due to the lack of
suitable techniques for qualitative and quantitative
determination of prostaglandins. In the early 1960s, the
first isolation of crystalline prostaglandin was achieved
by Bergstrom and S jovail (1960) and its chemical
structure was subsequently elucidated (Bergstrom et al.,,
1962),- Recently, using sophisticated instrumentation,
analysts are'able to develop sensitive and specific
physico-chemical and biochemical methods for analysis of
prostaglandins.
(1) Extraction of Prostaglandins
Numerous methods for the extraction of PGs have been
developed. These include extraction by adsorption to
Amberlite XAD-2 (Green, 1971) and solvent extraction
(Unger et al., 1971). The advantage of the former method
is that it is useful for the extraction of all the primary
prostaglandins as well as for the major circulating and
urinary metabolites of PGE2 and PGF2d. Solvent extraction
is useful for the extraction of PGA, PGB, PGE, PGF and
thromboxane B (Frolich, 1973). In most extractions, the
biological sample is acidified to pH 3-4 with either dilute
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mineral acid (HC1) or acetic acid and then partitioned twice
with one, two or three volumes of a polar organic solvent
such as ethyl acetate or diethyl ether (Samuelsson, 1963;
Unger et al., 1970). In certain instances the initial
extraction may be with ethanol or n-butanol, and followed
by concentration and extraction as described above.
Alternative procedures are employed for the extraction of
prostaglandins from a range of biological sources including
the uterus, the kidney, urine and the blood (Horton, 1972;
Salmon and Karim, 1976).
(2) Separation of Prostaglandins
During the past decade a variety of chromatographic
procedures have been developed to improve the purifications
of prostaglandins by chromatographic techniques. These
techniques will be discussed in the following paragraphs.
(a) Thin-layer Chromatography
This chromatographic procedure has become increasingly
popular primarily because of its wide range of
applicability and ease of operation. Many of the solvent
and support systemsin use are modifications of those
reported previously (Green and Samuelsson, 1964;
Andersen, 1969a). Green and Samuelsson (1964) were able
to separate individual PGs with a different number of
double bonds using silica gel plates impregnated with
silver nitrate. Recently, Wickraniasinghe and Shaw (1973)
reported the separation of PGs A. B and C by thin layer
chromatography on silica gel impregnated with ferric
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chloride the resolution obtained was far superior to
that on silica gel plates impregnated with silver nitrate.
After development of thin layer plates, the PGs
can be visualised by spraying with a variety of reagents
(Shaw and Ramwell, 1969). Finally, PGs must be scraped
from the plate, extracted and assayed by other means.
(b) Silicic Acid'and Silica Gel Column Chromatography
The use of silicic acid and silica gel column
chromatography is almost as popular as thin-slayer
chromatography. Again, the procedures involved are
highly flexible, reproducible, simple to operate and
also allow the efficient separation of the various
prostaglandins.
Silicic acid has to be activated prior to use and
this is performed by heating 1 i 5°- 120°C for at least
b
1 hour (Samuelsson, 1963). The silicic acid is then
slurried in ethyl acetate-toluene (1:9 v/v-) and poured
into glass columns under free flow. In general,
PGA(PGB and PGC), PGE and PGFc are sequentially eluted
in steps of increasing ethyl acetate in toluene.. For
certain batches of silicic acid it may be necessary to
add small quantities of methanol to each eluant to ensure
complete recoveries. This chromatographic technique
is used for separation of PGs in the present study,
therefore detailed discussion will be described later
(see also pp. 87-88).
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Although silica gel column chromatography is not
as popular as silicic acid, it also has a wide range of
application. It can be used'for purification of blood
prostaglandins and prostaglandin intermediates (Corey
et l., 71 71).
(c) High Pressure Liquid Chromatography
Regently, high-pressure liquid chromatography has
found numerous applications and taken its place alongside
thin-layer and gas chromatography. Modern column-packing
methods and pumps result in highly efficient separations
on columns packed with very small particles which are
eluted under high pressure and floc (for review, see
Heftrnann, 1975). A high reproducibility and recovery
of using high-pressure liquid chromatography technique
was reported (Frolica, 1977). Therefore, this method
is useful and convenient for analyzing PGE andZ, PGF2
their major circulating metabolites in the same plasma
sample or in kidney incubation (Green et al., 1973).
(d) Reversed Phase Partition Chromatography
This system employs hyflo supercel (hydrophobic
celite) as the support medium for separation of PGs.
The chromatographic process has proved to be highly
versatile for purification of PGs and their metabolites
(Hensby, 1977).
Preparation of the hydrophobic celite has been
described elsewhere (Shaw and Ramwell, 1969). In practical
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operation, hyflo supercel reversed phase chromatography
systems, when used in combination with other chromatographic
techniques such as silicic acid and thin layer
chromatography, have been extensively used for the
purification of prostaglandins and metabolites from a
wide variety of sources (Samuelsson, 1964).
(e) Lipophilic Sephadex Gel Column Chromatography
In this chromatographic system, a variety of column
supports are available from Sephadex and its derivates.
Due to the high recovery of separation, reusability,
mild chromatography condition employed (reducing chemical
instability) and simple technique, this method becomes
popular as analytical tools for prostaglandin research
(for details, see Hensby, 1977).
(3) Measurement of prostaglandins
(a) Bioassay
Bioassays have been extensively used for the
detection and quantitative estimation of PGs. Although
the main disadvantage associated with bioassay is lack
of specificity of tissues to PGs and interference due
to the presence of other substances in tissues and fluid
extracts. This limitation can be overcome by proper
methods of PG separation and specific antagonists to
other biological active substances that may be present
in assay extracts.
However, the use of bioassay methods is still
widespread because of its rapidity in estimation and
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easy evaluation of the physiological potencies of PGs.
In most cases of PG bioassay, various gastrointestinal
smooth muscle preparations or mesenteric vascular beds
from mammals are often used (weeks et al.,-1968
Vane, 1969 Ambache, 1966 Bergstrom et al., 1968)o Full
accounts of bioassay methods is described by Sal:ncm and
Karim (1976).
(b) Rad io immuno as s ay
Antibodies against a prostaglandin-protein conjugate
have been successfully raised in mammals. The resultant
circulating antibodies are obtained (antisera) and used
for the assay of the prostaglandin concerned. The assay
itself is based upon isotope dilution radioactively
labeled prostaglandin (usually 3H or 14C) to which the
antisera were raised is used to construct binding curves
for the antisera against the non-labelled prostaglandin.
The antisera is then used to compare the effects of
various biological samples on the binding of the
radioactive label to the antisera. In this manner, a
sensitive and relatively selective assay for a given
prostaglandin is obtained (Jaffe and Behrman, 1974*
Caldwell et al.t 1971). However, it must be mentioned
that any compound that will inhibit the binding of the
radioactive label will be assayed as that given
prostaglandin, and thus the results should be expressed
as prostaglandin. equivalents unless confirmed by two or
more assay methods.
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(c Detection of Prostaglandins by Gas Liquid Chromatography
with Flame Ionization, Electron Capture and Mass
Spectrometry
Many detector systems are available to measure the
effluent from a gas-liquid chromatography but only
three have been used extensively for PG analysis,.namely:
(i) flame ionization detector (FID) ;(ii) electron
capture detector (ECD) ;(iii) mass spectrometer (MS).
The sample preparation is basically the same for each
system (see Salmon and Karim, 197).
Both flame ionization and electron capture detectors
are relatively non-specific by comparison with a mass
spectrometer. With flame ionization-detection, any
compound that elutes,from gas-liquid chromatography
column and combusts in the presence of hydrogen and
oxygen to produce ions will be detected. This is a
feature which prostaglandins share with almost all other
organic compounds. Nevertheless, both flame ionization
and electron capture detection have been successfully
applied to the gas-liquid chromatography of prostaglandins
and their metabolites (Albro and Fishbein, 1969;
Pace-Asciak and Wolfe, 1971; Keirse and Turnbull, 1973).
The use of a mass spectrometer as a method of
detecting prostaglandin derivatives is increasingly
proving to be one of the most sensitive and selective
developments in the physical analysis of prostaglandins.
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However, its sophistication, time consumption and high
expense make this method unsuitable for routine use.
Moreover, the mass spectrometer has a greater degree
of specificity to the analysis of compounds being eluted
from the gas chromatograph. Hence, applications of mass
spectrophotometry are of great importance in the structure
elucidation of the prostaglandins and their derivatives.
(see also Fralish, 1977).
(d) Ultra--violet Spectrophotometry
The dienone structure present in PGB compounds has
a. characteristic ultra-violet (UV) absorption with a
max (in ethanol) at 278nm. The Beer-Lambert law accurately
represents the relationship between concentration and
absorbance so that PGB may be quantitatively estimated
using a spectrophotometer (Shaw and Ramwell, 1969).
PGE and PGA compounds are converted to the corresponding
PGB by treatment with alkali (Samuelsson, 1964 Zusman,
1972) which can then be measured.
(e) Zimmermann Reaction
The basic principle of Zimmermann reaction is the
formation of a coloured product by the reaction of ketone
with m-dinitrobenzene in alkaline condition. This coloured
product has an absorption peak at 580 nm (Cork et al., 1962).
The procedure is simple and relatively inexpensive
but the sensitivity of the method is low.
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(VI INHIBITION OF PROSTAGLANDIN BIOSYNTHESIS BY
ASPIRIN-LIKE DRUGS
'Aspirin-like' drugs are pharmacological agents
with diverse chemical structures. However, they all share
(to a varying degree) antipyretic, analgesic and
anti-inflammatory actions which are characteristic of
aspirin. The aspirin-like drugs include: meclofenamic
acid, niflumic acid, indomethacin, mefenamic acid, flufenamic
acid, naproxan, phenylbutazone, aspirin and ibuprofen,
which are frequently studied in recent research.
In 1971, aspirin-like drugs were shown to inhibit
prostaglandin release from human platelets by Smith and
Willis. Aspirin also inhibits prostaglandin release from
perfused dog spleen (Ferreira et ale, 1971) and
prostaglandin synthesis in cell-free homogenates of
guinea-pig lungs (Vane, 1970*
(1) Inhibition of Synthesis
Inhibition of prostaglandin synthesis by aspirin-like
drugs has now been demonstrated in many different systems
(see Table 4). For the purpose of review, studies on the
inhibition of aspirin-like drugs are divided into three
categories:
(a) Homogenates and subcellular fractions
'Mie:rosomal' preparations of tissue homogenates
have been widely used, since the synthesising enzymes
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Table 4. Summary of systems in which prostaglandin synthesis is
inhibited by aspirin-like drugs.
TissueSpecies References
PlateletHuman Smith and Willis (19 71)
Semen Collier and Flower (1971)
Whole body Hamberg (1972)
Skin Ziboh et al. (1973)
Urinary metabolite
Cavanaugh et al (1980)Prostate gland
Smith and Lands (19 71)Seminal vesicleSheep
KidneyDog Aiken and Vane (1971)
Spleen Ferreira et al. (1971)
Brain Flower and Vane (1972)
Platelet Flower et al. (1972)




Lungs Palmer et al. (1973)
Whole body Hamberg and Samuelsson (1972)
Jejunum Ferreira et al. (1972)Rabbit
Flower and Vane (1972)Brain
Aiken and Vane (1971)Kidney
Eakins et al. (1972b)Eye
Aiken (197 2)Pregnant uterusRat
Inflammatory exudate Greaves and McDonald-Gibson (1972)
Wong et al. (1972)BladderToad
47
are located in this fractions.
From comparison of inhibition action of aspirin-
like drugs, it is possible to deduce the order of
(decreasing) potency (Flower, 1974) meclofenamic acid
>niflumic acid or indomethacin> mefenamic acid
>flufonamic> acid naproxen> phenylbutazone >aspirin
or ibuprofen. This order of potency is, generally
speaking, consistent with all the data so far published
regardless of the source of the synthetase although
some minor variations have been reported (Ham et al.,
1972).
Aspirin or indomethacin have been found to be
effective in inhibition of PGE2 and PGF24 production
in guinea-pig uterus. (Poyser, 1972). Indomethacin was
a strong inhibitor of E2 and F20 production by
microsomal preparations or homogenates of rabbit spleen
(Bhattacherjee and Eakins, 1973) and kidney medulla
(Tai and Hollander, 1973).
(b) Isolated tissues
The ability of aspirin-like drugs to inhibit release
in tissues was first shown by Smith, and Willis (1971)
and by Ferriera et al. (1971). Smith and Willis (1971)
found that aspirin-like drugs inhibited production of
PGs in human platelet in vitro. Indomethacin was about
10 times more potent than aspirin which was in turn more
potent than other salicylate. Gryglewski and Vane
(1972) found that PGs are released when slices of
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rabbit spleen are mechanical stimulated, and used this
preparation to test the potency of inhibition of PG
synthesis caused by aspirin-like drugs. The order of
decreasing potency was found to bemeclofenamic acid.
>indomethacin >oxyphenbutazone >aspirin.
Whole animals and man(c)
Collier and Flower (1971) as well as Horton et al.
(1973) showed that the amount of PGE 2 and PGF2Q in
human semen was decreased by oral intake of aspirin.
Inhibition of prostaglandin synthesis in whole
animals has been shown in other species. Administration
of indomethacin to dogs, cats and rabbits abolishes
the release of PGs from kidney in response to angiotensin
injections (Aiken and Vane, 1971) haemorrhage or
endotoxin-induced hypotension (Collier et al., 1973).
(2) Mechanism of Inhibition Action
The chemical diversity of aspirin-like drugs indicates
the possibility of more than one mode of action. Several
possibilities have been suggested (Flower, 1974)
competition with substrate or cofactor on the enzyme site,
irreversible inactivation of enzyme, chelation, or a free
radical destruction mechanism.
The majority of the aspirin-like drugs are organic
acids and so the simplest hypothesis would envisage a
straight competition between drug and substrate.at the
catalytic site. Indeed, some results appear to support this
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concept. Flower et al, (1973) found that the degree of
indomethacin inhibition was dependent on the substrate
concentration.
However, other workers (Smith and Lands, 1971 and
Lands et al., 1973) showed that the majority of the common
aspirin-like drugs are 'competitive irreversible' inhibitors.
Two possible situations may prevail (Curtis-Prior, 1976):-
(a) Inhibitor irreversibly binds to the dioxygenase system
catalytic site. In the presence of substrate the velocity
of this combination is reduced. Since the initial degree
of inhibition is a function of substrate concentration,
competition arises.
(b) This is similar to the first case but the inhibitor binds
adjacent to the catalytic site and reduces it affinity
for the substrate, allosterically.
In summary, most of the aspirin-like drugs block the
initial stages of the synthetase reaction in a 'competitive-
irreversible' fashion. They probably exert this effect
by combining slowly with a site which, although not the
substrate site, is sufficiently close to reduce the
catalytic activity of the enzyme in a time-dependent
fashion. Some compounds may affect endoperoxide
breakdown but this cannot be regarded as definitely proven.
(3) Sensitivity of Aspirin-like Drugs
Due to a wide variation in sensitivity to aspirin in
different tissues, Vane (1972) therefore, proposed that the
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PG generating system exists in multiple molecular forms
within the organism. The synthetase enzymes from each tissue
type have a different pharmacological profile.
Bhattackerjee and Eakins (1973) tested the inhibitory
potency of indomethacin against various rabbit tissues.
The drug showed good activity against enzyme preparations
from spleen, but was less active against kidney enzyme and
evenmore, relatively inactive against the synthetase
prepared from retina.
Furthermore, different potencies of these drugs against
the same tissue taken from different species were reported.
For example, doses of indomethacin to produce the same
potency of inhibition in dog (0.17 pm) and rabbit spleen
(0.14 um) are different (Flower et al., 1972).
In addition, PG synthetases prepared from different
tissues show different sensitivities to aspirin-like drugs.
This reflects the possible existence of a series of
isoenzymes and can explain the variations in activity within
the group of compounds. However, a regional pattern of PGE2
biosynthesis inhibition by indomethacin in rabbit kidney was
reported (Attallah and Stahl, 1980). Cortical inhibition
is found to be more 'profound than medullary and papillary
response. They suggest that uneven distribution of blood
flow and/or organic acid transport could lead to a higher
concentration of the drug in the cortical region.
Moreover, potent prostaglandin synthetase inhibitors
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are useful tools for defining the role that PGs play in
the body, The evidence so far shows that PGs, as well as
being important mediators of inflammation (Ferrira and
Vane, 1974). fever (Milton and. Wendlant, 1971), pain
(Bergstrom et al., 1959 Collier et al., 1972) maintenance
of isolated smooth muscle tone (Ono al., 1979),
contribution to the explosion of the fetus (Aiken, 1972),
modulation of lipolysis (Illiano and Cu.atrecasas, 1971) and
catecholamine release (Gu llner et al., 1979) (For details,
see Ferreira and Vane, 1974)
In the present study, aspirin was used as a PGs-
synthesis inhibitor for the investigation of the function
of PGs in the snakehead.
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(VII) EFFECTS OF PROSTAGLANDINS
The ubiquitous distribution and local biosynthesis
of prostaglandins in various animal tissues have been
previously reported (see also p. 22). Because of this,
one would deduce that PGs may have versatile physiological
actions on body. Actually, PGs have a wide spectrum of
activities and individual compounds differ in their actions.
The physiological and pharmacological effects of
PGs in mammals have been well documented. They stimulate
as well as relax smooth muscles they affect the
cardiovascular system, acting as pressor agents under some
circumstances and as depressor agents under others. PGs
exert effects on adipose tissue metabolism and glucose
homeostasis. Furthermore, PGs have influence on
reproduction, inflammation, pulmonary physiology, renal
function, digestion, the immune response, blood cells
and hypothalamus-pituitary-endocrine system. Since PGs
possess a lot of physiological and pharmacological
activities only those effects which are relevant to the
present study will be discussed in detail.
(1) Cardiovascular effects of prostaglandins
In 1930s, Goldblatt(1933, 1935) and von Euler (1935)
independently observed the biological actions of extracts
of human seminal fluid and of sheep vesicular gland.
These extracts produced a fall in blood pressure
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and stimulated a variety of smooth muscle organs.
However, the comprehensive study of the pharmacology of
the prostaglandins only began with the.isolation and
characterization by Bergstrom and Sjdvall (1957) of
small quantities of two crystalline prostaglandins from
vesicular glands. These were designated PGE and PGF.
After this discovery, primary prostaglandins have become
readily available to numerous biologists.
Among various biological actions of prostaglandins,
their effects on cardiovascular system are first discovered
and most studied. In this section, the actions of PGs
on cardiovascular system will be discussed in detail (for
details, see also Malik and Mcgill, 1976).
(a) Prostaglandins E
The intravenous administration of an E-type
prostaglandin lowers the arterial blood pressure of
all species examined (rat: Holmes et al., 1963
Weeks and Wingerson, 1964, cat: Holmes et al., 1963,
mouse: Weeks, 1969, dog: Chapple et al.t 1980, Sanbar
et al.,1967 Glaviano and Master, 1968, rabbit:
Bergstrom and Euler, 1963, man: Bergstrom et al., 1959a
Carlson et al., 1969, Chicken: Horton and Main, 1967,
goose Grande and Prigge, 1972, carp: Peyraud-Waitzen-
egger et al., 1975). In most of these species the dose
of PGE1 or PGE2 required to lower arterial blood
pressure ranged from 0.1 to 10 ug/kg. Moreover, the
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action of PGE1, PGE2 and PGE3 on arterial blood
pressure was qualitatively similar. However, the
potencies of PGE varied in different animal species.
Hence, the threshold infusion dose of PGE1 required to
lower arterial blood pressure was 180 ng/kg/min in cat,
450 ng/kg/min in dog and 1 ug/kg/min in rabbit
(Horton and Jones, 1969). Prostaglandins E1 and E2 were
equipotent in most animal species. However, in rat and
dog, Weeks et al. (1969) found PGE2 to be somewhat more
active in lowering blood pressure than PGE1
The cardiovascular effects of E-type prostaglandins
were dependent upon the route of administration. Thus,
intra-aortic injections produced more pronounced changes
than intravenous injections (Bergstrom et alev 1964a).
Similar observations have been made by a number of
investigators (Carlson and Oro, 1966 McGill et al., 1969b
Nakano, 1971a) in rats and dogs. The difference is
explained by rapid uptake and/or metabolism of E
prostaglandins by the lungs and liver as well as rapid
diffusion from the blood (Ferreira and Vane, 1967
Horton and Jones, 1969 McGill et al., 1969b).
The fall in arterial blood pressure caused by
PGEs is most probably due to a decrease in total
peripheral resistance as a result of their direct
vasodilator action on resistance vessels. Arterial
injections of PGE1 have been shown to decrease the total
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peripheral resistance, the resistance in carotid,
femoral, brachial,coronary and renal vascular beds
of the dog (Nakano and McCurdy, 1967a Chapple et alet
1980), the hindlimb vasculature of the cat (Horton
and Jones, 1969), pancreatic vascular bed of rat
(Saunders and Moser, 1972) and mesenteric vascular
bed of pig (Hovenaghel et al., 1979).
Bergstrom et al, (1959) reported that the depressor
action of PGE1 was not prevented by doses of atropine
and antihistaminics sufficient to'block acetylcholine
and histamine-induced vasodepression, respectively.
PG-induced fall in blood pressure was also not abolished
by vagotomy or after the administration of various
anaesthetic drugs (Giles et al., 1969), /3 -adrenergic
blockade (Carlson and Oro, 1966), ganglionic blocking
agents (Carlson, 1967 DuCharme and Weeks, 1967) and
anticholinergic substance (Chapple.et al., 1980).
From these results, we can conclude that vasodilation
and the associated decrease in arterial blood pressure
produced by PGEs was not mediated through cholinergic
mechanism, release of histamine, stimulation of
-adrenergic receptors or, through blockade of
-adrenergic receptors.
Moreover, PGE1 diminished the angiotensingepinephrine-,
norepinephrine- and vasopressin-induced increase in
blood pressure (Weiner and Kaley, 1969). It suggests
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that the abolishment of vasopressor substances induced
blood pressure elevation may be due to the summation of
two oppositive effects.
The PGE-induced decrease in blood pressure was
accompanied by positive chronotropic and inotropic
effects in dog (Nakano and McCurdy, 1967). However,
PGE1 did not increase the heart rate in vagotomized and
intact dogs pretreated with pronethalol (adrenergic
blocker), reserpine ((2 -adrenergic .blocker) and ganglionic
drugs (Carlson and Oro, 1966 Nakano and McCurdy, 1967),
but these treatments did not affect the vasopression.
It would, therefore, show that the ^hronotropic effect of
PGE in intact dogs is mediated through reflex sympathetic
stimulation asAconsequence of the decreased systemic
A
arterial pressure.
However, cardiovascular response to
intracerebroventricular injection (IVT) of PGE2 showed
the contrary. This treatment resulted in elevation of
blood pressure and tachycardia in rat (Hoffman and Schmid,
1979 Anderson and Leskell, 1975 Leskell, 1976
Kondo et al., 1979).-adrenergic blockade inhibited
pressor response of IVT of PGE2 but could not alter the
effect on heart rate (Hoffman and Schmid, 1979). Moreover,
-adrenergic blockade inhibited tachycardia but not
pressor effect and atropine attenuated heart and blood
pressure responses to PGE2. These results indicate that
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IVT PGE2 injection produces pressor and tachycardia
response in the unanaesthetized rat which are mediated
primarily by centrally mediated sympathetic outflow.
The cardiovascular actions of PGE have been well
documented in mammals. However, to the best of the
author's knowledge, there are only three reports on
non-mammals. Chiu and Leung (unpublished) studied the
PGE1 effect on perfusion flow rate in the perfused frog
kidney. PGE1 did not alter the perfusion flow rate in
this preparation. In addition, PGE2 intra-arterial
injection induced a prolonged depression of arterial
pressure associated with an initial bradycardia
followed by tachycardia and hypertension in carp
(Peyraud-Waitzenegger et al., 1975).
(b) Prostaglandins A
Prostaglandins of the A series are derived from
E prostaglandins by dehydration which results in a
marked relaxation on smooth muscles of the gastrointestinal,
respiratory and reproductive tracts, but an increase
in the dilatory activity of cardiovascular smooth
muscles (Bygdeman et al., 1966 1966 Weeks et al., 1969).
Cardiovascular effects of A prostaglandins are
qualita.tively similar to E prostaglandins. PGA1 and
PGA2 have a potent blood pressure lowering effect in
both coiscious and anaesthetized dogs and rats
(Lee et al., 1965 Weeks, 1969 Higgins et al., 1970,
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1972 Greenberg et al.,1974), anaesthetized cats
(Kannegiesser and Lee, 1971) and rabbits (Horton and
Jones, 1969). Similar to E prostaglandins, the activity
of A prostaglandins varies in different animal species
(Horton and Jones, 1969). PGE1 and E2 were more potent
than PGA1 or PGA2 on intra-aortic administration to the
cat, whereas a positive result of intravenous injection
was reported (Kannegiesser and Lee, 1971). This difference
is due to the fact that intravenous injection necessitates
passage through the lungs which selectively inactivates
E prostaglandins but not A prostaglandins which pass
freely across the pulmonary circulation (Ferreira and
Vane, 1967 McGill et all., 1969). The inability of the
pulmonary circulation to inactivate A prostaglandins is
most likely due to their lesser specificity for
15-hydroxy-prostaglandin dehydrogenase than those of the
E series (Nakano et alot 1969).
Like PGE, the hypotensive effect of A prostaglandins
is most likely due to marked dilatation of the peripheral
vasculature resulting in a decrease in total peripheral
resistance (Horton and Jones, 1969 Weeks et al., 1969).
Similar to PGE, PGA also promotes heart rate and
myocardial contractile force. -adrenergic blockade
prevented PGA-induced increase in heart rate whereas- it
could not change the vasodepressor action by PGA1
(Higgins et al., 1971).
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(c) Prostaglandins B and C
Prostaglandins of the B and C series are formed
from A prostaglandins by the action of a prostaglandin
isomerase which has been shown to be present in the
plasma of a number of animal species (Jones, 1972
Jones and Cammock, 1973). The vasodepressox' potencies
of PGE1, PGAZ, PGB1 and PGC1 was compared by Jones (1972).
Relative to PGE1(= 100), PGAZ, PGB1 and PGC1 had potencies
of 16, 0.9 and 44 respectively, Similarly, PGA2, PGB2
and PGC2 possessed 16, 1.2 and 47% of the activity of
PGE2. From this observation, it showed that PGB1 and B2
are relatively impotent in cardiovascular action. PGC1
and C2 are comparatively potent than PGA1 and A2. PGC1
also lowers vascular resistance and possesses an inotropic
action (Jones et al., 1974). However, PGB1 was a more
potent depressant of left ventricular pressure than PGB2.
PGB1 and B2 also decrease the heart rate in the dog,
PGB1 being less potent than PGB2 (Greenberg et al., 1973).
These agents constricted the perfused hindlimb and
hindpaw vasculature (Greenberg et al., 1973).
(d) Prostaglandins F
There are considerable species variation in the
effects of PGF2( and related F compounds on the
cardiovascular system. In rat and dog, PGF is a pressor
agent (DuCharme et al., 1968). It was shown that PGF2
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has a potent constrictor action on small veins in the
dog hindlimb and that cardiac output was raised with no
change in calculated peripheral resistance (DuCharme
et al., 1968). It was suggested that PGF2X raised the,
blood pressure primarily by peripheral venoconstriction.
Other workers disagree with this conclusion. Nakano and
Cole (1969) have shown that PGF2c4 increased cardiac output
and total and regional peripheral resistances and decrease
systemic venous return by sequestration of blood in the
splanchnic vascular beds. They suggested that an increase
in cardiac contractility and constriction in arterial beds
are mainly responsible for the pressor effect of PGF
Emerson and co-workers (1971) also emphasized the
arteriolar constrictor activity of PGF24 in the dog.
Furthermore, PGF2QC increased vascular resistance in the
isolated perfused rat pancreas (Saunders and Moser, 1972)
and mesenteric vascular bed in pig (Schrauwen et al., 1979).
In the isolated rat heart, PGF10( increases the
contractile force of the ventricles at low concentrations
in the perfusate (Vergroesen et al. 9 1967).. Thus, it is
possible that the pressor effect in the rat is partly due
to direct cardiac stimulation.
In addition, the vascular effects of PGE and PGF
on different tissue preparations have been fully described
(Nakano, 1973)6
(e) Prostaglandins I (prostacycln)
The studies of cardiovascular effects of PGI really
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began in the late 1970s. PGI2 is a potent vasodepressor
substance (Ten Berg et a1., 1980 Kondo et al., 1980) which
survives passage through the lungs (Pace-Asciak el al., 1978,
1979 Chapple et al., 1980). While it was about twice as
active as prostaglandin E2 in lowering the arterial blood
pressure of the normotensive rat, it was 3-4 times more active
in the spontaneously hypertensive rat (Pace-Asciak et al.,
1978). PGI2 also reduced aortic pressure and total peripheral
resistance and induced bradycardia (Chapple et al., 1980).
Atropine (Cholinergic blocker) reduced bradycardia and hypo-
tensive effects induced by PGI2 (Chapple et al., 1980). After
vagotomy, the hypotensive effects of PGI2 was also reduced.
These results reflects that hypotension induced by prostacyclin
is due to two components: (1) a direct relaxation of vascular
smooth muscles and (2) a reflex, non-cholinergic vasodilatation.
The bradycardia is reflex in nature and is partially mediated
by the vagus pathway.
PGI2 attenuated pressor responses to norepinephrine in
conscious rats (Okuno et al., 1980). A dose dependent
antihypertensive effect caused by PGI2 in conscious rats with
spontaneous and chronic renal hypertension was reported
(Schdlken, 1978 and Pace-Asciak t,al., 1979). However,
intracerebroventricular:administration of PGI2 and PGE2
elevated arterial blood pressure (Kondo et l., 1979).
An age-dependent increase in PGI2 biosynthesis capacity
was observed and reached maximum by three months of age
in the Anotaneously developing hypertensive rat
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(Pace-Asciak and Carrara, 1979). This indicates that
enhanced synthesis of the potent vasodepressor PGI2 in the
rat is likely to be an adaptive mechanism for the
attenuation of the substained elevation in blood pressure
in this animal model. Moreover, PGI2 survives pulmonary
transit for sufficient time to elicit a biological action
(Pace-Asciak et al., 1979). Thus, its continuous systemic
vascular synthesis could play an important role in the
control of hypertension.
(f) Prostaglandin precursors
The PG precursors, arachidonic acid (AA), is a potent
vasoactive agent. The AA infusion-sin.duced decrease blood
pressure and increase vascular resistance in dog (Mullane
et a1., 1979), rat (Damas and Troquet, 1978 Damas, 1978
Okuno et al., 1980 Ten Berg et al., 1980) and pig were reported
(Houvenaghel et al,, 1979 Schrauwen and Houvenaghel, 1978).
However, cardiac effects of AA are variable. Administration
of AA produced positive inotropic effects on the dog heart
(Rose et l., 1974), whereas AA-induced bradycardia was
reported by (Mullane et al., 1979). Irrespective of
AA-induced positive inotropia or bradycardia, all of the.
cardiovascular effects of AA are abolished by indomethacin
(Mullane et al., 1979 Okuno et al., 1980; Damas and Volon,
1978). These results indicate that AA-inciucea
cardiovascular effects is mediated by biotransformation
to active PGs. Besides, inhibition of prostaglandin
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synthesis by indomethacin did not change the blood pressure
of conscious rats. The endogenous prostaglandins seers
to play a minor role in direct regulation of systemic
blood pressure in conscious rats (Kondo et a1., 1980).
However, indomethacin potentiated the vascular reactivity
to norepinephrine (Kondo et al,, 1980) suggesting that
the endogenous prostaglandins act to inhibit the
norepinephrine response in the systemic circulation.
Other PG precursors, such as Dihomo-T-linolenic
acid exerts similar cardiovascular effects as AA and their
effects are abolished by PG synthetase inhibitors
(Rose and Kot, 1977).
Finally, which AA intermediate(s) is/are responsible
for the obserable cardiovascular effects remains unknown.
Data suggest that AA circulatory effects are not due to the
primary prostaglandins PGE2 and PGF2, but rather to
potent intermediates in PG synthesis or other end products
of AA metabolism (Rose and Kot, 1977).
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(2) Metabolism Effects of Prostaglandins
In early 1960s, there was a great development on the
chemistry of Prostaglandins. Since the isolation and
purification of Prostaglandins (Bergstr8m and Sjovall, 1960).
these compounds became available for study of their
biological actions. Later, the well-known effects of PGs
on blood pressure and on smooth muscle had been published.
Due to their remarkable biological potency, this led
Steinberg et al. (1963) to propose that PGs might also play
hormonal or regulatory roles beyond the actions on blood
pressure and smooth muscle. Therefore, they tested the
effects of Prostaglandins on fatty acid release in adipose
tissue. The outcome showed that PGs at extremely low
concentrations, suppressed basal lipolysis in rat epididymal
fat pads in vitro. After this finding, many biologists
begin to study the metabolic effects of PGs. However,
only the effects of PGs on free fatty acid and glucose
metabolism have been well documented. This section will
mainly discuss these two aspects of metabolic effects of
PGs.
(a) Free fatty acid (FFA) Metabolism
(i) In vitro effects
The first observations of the effects of
Prostaglandins on lipid metabolism were made by
Steinberg et al. (1963, 1964) and by Bergstr8m et al,
(1965). Steinberg and co-woriers (1964) showed that
PGE1 reduced basal lipolysis in pieces of epididymal
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adipose tissue and those incubated with adrenaline,
noradrenaline, ACTH, TSH and glucagon. At that time,
of course, the mechanism of this antagonism could not be
explained.
The release of free fatty acid from adipose tissue
triglycerides (TG) is regulated by the sympathetic nervous
system and by a variety of hormones activating the hormone
sensitive lipase.
Lipase can be activated and inhibited at different
levels. Activation is induced by hormones stimulating
adenyl cyclase (AC), an enzyme cycling ATP into cyclic
adenosine 3', 5'-monophosphate (cyclic AMP) which is a
nucleotide acting as a secondary messenger in various
organs (Fig. 9).
Butcher et al. (1967, 1968) suggested that anti-
lipolysis action of PGE1 was associated with formation of
cyclic AMP which in turn activated intracellular
triglyceride lipase (Rizack, 1964). Haessler and Crawford
(1967) independently noted the similar action of PGE1 and
insulin in anti-lipolysis.
The relative potencies of several PGEs in blocking
epinephrine-induced lipolysis were compared (Handler et al.,
1965). PGE1 was more potent than PGE2 PGE was ineffective
even at 1 pg/ml, although an effect could be demonstrated
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Fig. 8 A. hypothetical scheme of negative feed-back
inhibition of adipose cell lipolysis by
prostaglandins.
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potent than PGF1 or PGF1A and PGE2 more potent than PGF2
These relative potencies resemble those for depression
of blood pressure.
Shaw and Ramweli (1968) extended and correlated these
findings and showed that when epididymal adipose tissue
was stimulated in vitro by lipolytic hormones (eg. adrenaline,
noradrenaline and ATCH) or when the epididymal nerve was
stimulated electrically, or when animals were previously
fasted, there was an increased efflux of prostaglandins
associated with the enhanced free fatty acid release.
Furthermore, there was a reduced release of PGs (concomitant
with reduced FFA release) in the presence of insulin..
This led these workers to propose that PGs are involved in
maintenance of adipose tissue homeostasis by way of a
physiological negative feed-back control mechanism (Fig. 8)
Colin and William (1974) also reported the existence of PG
biosynthesis in ,rat isolated fat cells and negative feed-back
regulation of synthetic activity. Similar findings were
obtained by Christ and Nugteren (1970) who also showed a
decrease PGE2 release and an increased rate of adrenaline.
and theophylline-stimulated lipolysis in essential fatty
acid-deficient rats.
Aktories et al.( 1979) demonstrated that PGs and
-adrenergic agonists (e. g. nicotinic acid) reduced hamster
fat cell adenylate cyclase activity only in the concurrent
presence of GTP and Na+ ion (GTP 10 1um and Na Cl 120 mM)
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in hamster adipocyte ghost. GTP has recently been shown in
various tissues to be absolutely. necessary for the inhibition
of adenylate cyclase by o[-adrenergic and cholinergic agonists
(Watanabe et al., 1979). The exact mechanism of requirement of
Na in inhibition of hamster fat cell adenylate cyclase by PGE1
remains unclear. It suggests that Na+ may be involved in the
transduction of the inhibitory signal to the adenylate cyclase
or on the hormone binding.
However, Kather and Simon (1979) showed that adenylate
cyclase of human fat cell ghosts shows a biphasic response
towards PGE2 with inhibition occurring at nanomolar con-
centrations of the hormone and stimulation at concentrations
beyond 10- 6 mol/liter. The expression of the inhibitory effect
is critically dependent on GTP. This result is thus compatible
with the concept that the antagonistic effects of the PGE on
lipolysis are mediated via interaction with the membrane-bound
adenylate cyclase thereby suggesting that the role of these
hormones is more complex than assumed by the negative feed-
back concept. They proposed that the actual effects of PGs
are the result of a delicately regulated balance between two
opposing PG effects, which is not only dependent on the con-
centration of these C-20 fatty acids. However, this suggestion
still requires to be elucidated.
(ii) In vivo effects
The effects of PGs on plasma lipid are dependent upon
the dose of PGs and the kinds of animals. PGA1 infusion in
anesthetized dog produced an increase in plasma FFA level
(Sacca et al., 1973) and PGE injection also elevated the
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plasma FFA and glycerol level in man (Bergstr8m et a1., 1965)
and in goose (Grande and Prigge, '1972). However, Sanbar
et al. (1967) reported a contradictory result and plasma
FFA level was lowered by injection of PGE1.
Moreover, intravenous infusion of PGE1 in non-
anaesthetized dog showed a dose-dependent response in plasma
FFA level: low doses increased whereas high doses decreased
plasma FFA level (Bergstrdim et a1., 1966). Bergstr6m et al.
suggested that low dose of PGE1 stimulated-the sympathetic
nervous activity (enhanced lipid mobilization) while high
dose of PGE1 has a direct inhibitory effect on FFA
mobilization from adipose tissue.
a
Carlson et al. (1970) showed no PGE1 antagonism of
noradrenaline-induced FFA release in vivo in man but explained
their findings by the suggestion that this PG is not normally
transported by the blood to adipose tissue in vivo. At the
same time, human adipose tissue incubated in vitro showed
a significant inhibition of lipolysis by PGE1. In more
recent experiments in man, several PGs (A1, E2, F1 , F1
and Fz have been infused into healthy subjects in doses
ranging from 0.056 to 0.56 dug/kg/min (Carlson et al., 1970)
PGA1 and PGE2 induced a modest increase in heart rate and
plasma FFA *but F series of PG produced no significant changes
in the heart rate and plasma FFA level.
The finding that insulin has similar actions as PGE1
in counteracting the effects of epinephrine on cyclic AMP
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accumulation and on lipolysis in adipose tissue has been
discussed( p, 65).
Bressler (1968) first reported that PGE1 induced an
increase in plasma insulin level in mice. Later,
Rossini et al .(1971) showed that PGE1 and PGA1 could not
induce release of insulin in isolated rat islets. They
postulated that the increase in PG-induced insulin release
in vivo is the result of regional increase in pancreatic
blood flow. However, Lefebvre and Luyckx (1973) showed
that in vivo intravenous administration of PGE1 in dogs
caused a significant drop in arterial blood pressure and
in pancreatic duodenal vein pressure. At cessation.of
infusion there was a very significant increase in insulin
release accompanied by slight hypoglycemia.
Others have found that prostaglandin E1 and E2
lowered circulating insulin levels and blunted insulin
responses following intravenous glucose loading
(Robertson, 1973). Similar results have been shown for
PGA1 in fasting dog (Sacra et al9q 1973). However, it is
still not possible to establish whether such an effect
depends on a direct action of PGA1 on pancreatic beta cells
or it results from an indirect mechanism, eg., a sympathetic
activity.
(b) Glucose metabolism
Besides PGs have effects on lipolysis, they also
affect glucose metabolism.
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(i) In vivo effects
PGE infusion produces hyperglycemic effects in
anaesthetized and conscious dogs (Bergstrom et al., 1Q66
Sanbar et a1., 1967), goose (Grande and Prigge, 1972)p
rat (Berta et a1., 1965) and guinea-pig (Berta et al.
1965). Intravenous PGA1 infusion also elevated plasma
glucose level in anaesthetized dog (Sacca et al., 1973).
Moreover, PGE1 infusion produced an increase in
plasma glucose and decrease in plasma FFA level in intact
rat while the hyperglycemic effect was abolished in
adrenal medullectomized rat (Berta et al.9 1967). In these
treated rats PGE1 fully retains its effect on plasma FFA.
These data indicate that the PGE1 effects on plasma FFA
and blood glucose are due to different mechanisms and
that hyperglycemia depends on hypersecretion of medullary
catecholamines. Therefore PGE1 releases endiogenous
catecholamines,and is able to antagonize the effects of
these hormones on lipolysis but not on glucose mobilization.
(ii) In vitro effects
Vaughan (1966) observed that PGE1 has a slight but
significant effect on glucose uptake by rat epididymal
adipose tissue whereas PGA1 was ineffective. PGE1 was
also insulin-like in stimulating synthesis of fatty acids
and glycogen from glucose.
In experiments on incubation of liver slices with
PGE1, Bohle and May (1967) found a decrease in glycogen levels.
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However, Berti et al. (1967) suggested that the hyperglycemic
effect of PG is mediated via catecholamines. Therefore,
the results of Berti al. and Bo'hle and Mayts conclusion
are apparently in contradiction. Furthermore, Lemberg
et al. (1971) reported that PGE1 infusion induced a
significant increment in the average glucose levels in the
perfusate of the isolated perfused rat liver. On the other
hand, Wilson and Levine (1970) described a decrease in
labelled glucose incorporation in rat liver perfusions in
the presence of PGE1. In addition, PGE1 decreases the basal
rate of glucose production and'abolishes the increase usually
caused by glucagon or cyclic AMP (Wheeler and Epand., 1975).
This effect is mimicked by insulin and indomethacin, both of
which also decrease PG levels. It suggests that inhibition
of the synthesis of a reactive metabolic intermediate in
PG biosynthesis may explain these apparently anomalous
effects.
Since PGE infusion induces hyperglycemia in most animals
so far studied and liver provides the ample source of glucose
in the body, a study of PG action on liver enzyme systems
has been repeatedly emphasizedo
PGE1 has been shown to have insulin-like effects
(Vaughan, 1966 Bohle et al., 1967) and to alter cAMP levels,
either increasing or decreasing them in various tissues
(Ramwell and Shaw, 1970). Two enzyme systems are involved:
glycogen synthetase (glycogen synthesis key enzymes) and
glycogen phosphorylase (glycogen degradation enzymes) of rat
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liver which are known to be influenced by alternations
in concentration of CAMP and by insulin, Both enzymes
exist in physiological active and inactive forms. It was
found that PGE1 caused a significant decrease in glycogen
synthetase activity regardless of nutritional status or
presence or absence of adrenal glands (Curnow and Nuttall,
1972). ]Furthermore, adrenergic and ganglionic blockade
did not diminish the response of the synthetase system
to PGE1. On the contrary, PGE1 promoted a significant
increase in liver phosphophosphorylase activity in fasted
intact rats which could be completely inhibited by
ganglionic blockade and partially inhibited by -adrenergic
blockade, It was concluded that the in vivo effects of
PGE1 on the synths to se and pho spho spho sphoryla se are
mediated through different mechanisms. These changes in
enzyme activities are compatible with increased hepatic
CAMP and suggested possible direct effects on hepatic
glycogen level, On the other hand, Exton et al. (1971)
and Levine (19741979) showed that PGE1 and PGE2 perfusion
in rat liver failed to alter CAMP levels or glucose
production. PGE1 did not promote hyperglycemia,
glycogenolysis, lipolysis or prevent epinephrine-induced
hyperglycemia in the isolated perfused rat liver
(Levine, 1979). Moreover, PGE2 alone does not influence
hepatic gluconeogenesis from lactate but does suppress
glucagon mediated gluconeogensis and CAMP production in
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isolated rat liver (Dehubertis et al., 1974 Levine and
Schwartzel, 1980).
From the above discussion of in vivo and in vitro
effects of PGE on glucose metabolism, there is no general
conclusion on the mechanism of PG actions. Until now,
the other PGs, such as PGA, PGF and PGB, their actions. on
fatty acid and glucose metabolism has seldom been examined.
Further studies on the mechanism of PGE action and on the
metabolic effects of other PGs are required.
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(3 Osmoregulatory Effects of Prostaglandins
Prostaglandins have been woll known in modulating
blood pressure. In the kidney, they are produced locally
(Weber et al., 1979) and seem to increase renal blood
flow and to promote natriuresis (Scherer et al., 1980
Oliw, 1979). However, the role of renal PGs in the handling
of sodium-and potassium-chloride is still under debate
For PGE2, both natriuretic (Papanicolaon et al., 1976)
as well as antinatriuretic (Scherer et al., 1977) actions
have been proposed, while sometimes no clear relationship
could be*found (Scherer and Weber, 1979). A review of the
role of prostaglandins in the control of sodium excretion
has been published (Kirschenbaum and Serros, 1980).
-Kirschenbaum and Serros suggested that prostaglandins
may not have one consistent, uniform role in sodium
excretion and they act not by themselves but rather in
concert with numerous other natriuretic and antinatriuretic
factors to control sodium excretion.
It has been reported that renal PGE2 formation is
reduced by high NaC1 intake and enhanced by low NaCl intake
and in hypokalemic states (Weber et al. 1979). These
findings make renal PGEts good candidates for participation
in the regulation of salt and water balancc and in the
control of blood pressure. Moreover a participation of
PGs in the control of renin release has been reported (Oates
et al., 1979 Hockel and Cowley, 1980^9 Okahara et a1., 1980
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Sato et alot 1980). PGI2 and PGE2 has been shown to
increase renin activity in mammals (Oates et al., 1979).
Indomethacin, a blocker of prostaglarLdin synthesis,
lowered plasma renin activity, renal PG synthesis and
causes sodium retention in man (Fr8lich, 1980) A number
of laboratories have reported almost simultaneously on
effects of prostaglandins on. renin release (Donker et 1.,
1976 Frilich et a1., 1976 bars son et al, 1974
Romero et al., 1976). A more precise mechanism whereby
prostaglandins influence renin release is given showing
that the baroreceptor and the macula densa mechanisms
of renin release are affected by prostaglandins
(Freilich, 1980).
Since the collecting tubule has. been regarded as
playing a crucial role in regulation of Na excretion
in the final urine, the inhibiting effects of PGE1.
PGE2 and. PGF20C on Na absorption in the isolated collecting
tubules by acting on the peritubular membrane were studied
(lino and Imal, 197.8).
Moreover, the osmoregulatory effects. of PGs on the
other organs with osmotic participation have been published.
In isolated bullfrog small intestine preparation, addition
of PGE1 to the serosal medium elicited small increases
in transmural potential difference and short-circuit
current while addition of PGE1 to the mucosal medium
caused no change in the electrical parameters
(Gerencser et al., 1977).
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A number of reports have been published that PGs
are involved in water and ion transport in the isolated
toad urinary bladder (Halushka et al. 1980
Urakabe et a1., 1975 Lipson et al., 1.971). PGE1 alone
induced no significant change in osmotic water flow,
but stimulated the short circuit current and inhibited
vasopressin and theophylline-induced osmotic water flow
across the urinary bladder of the toad (Lipson et al., 1971
Urakabel et al., 1975) and PGE1 could not inhibit cAMP
induced increase in water flow (Urakabe et al., 1975).
These results suggest that PGE1 inhibits vasopressin and
theophylline-induced water flow by inhibiting adenyl
cyclase activity in the toad urinary bladder
(Lipson et al., 1971). In contrast to the effects on
water flow, PGE1 stimulated Na transport across the bladder.
This stimulation of transport can be potentiated by
theophylline, a finding that suggests an action. of PGE1
on adenyl cyclase and consequent stimulation of Na
transport by cAMP. Furthermore, a comparative study of
different PGs inhibition on vasopressin induced osmotic
flow in the isolated toad urinary bladder has been reported
(Urakabe et alev 1975). The potency of this effect was
PGE >PGF> PGA> PGB and 1 series >2 series.
Many types of invertebrate tissue contain (Nomura
and Ogata, 1976) or synthesize (Christ and Van Dorp, 1972)
prostaglandins. Therefore, PGs probably have many
physiological actions in invertebrate, PGE2 was identified
in Modiolus demissus (Bivalve) gill tissue and sea water
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incubated surrounding the tissue (Fereas and Grollman,
1980). Hyposmotic stress significantly increased release
of prostaglandins into sea water and increase PG. synthesis.
This indicates that PGs may have a physiological role in
the acclimation of Modiolus demissus to salinity stress.
Furthermore, PGE2 injected into the mussel (Ligumia
subrostrata) caused an 80% reduction of Na influx and
the animals experienced a net loss of Ida+. (Graves and
Dietz, 1979). Injection of indomethacin caused a doubling
of Na+ influx relative to the control animals. It is
concluded that Na transport in freshwater mussels is
apparently regulated, in part, by prostaglandins.
In fish, Pic(1975) observed that either PGF2 or
PGE1, could inhibit branchial Na+ and Cl- outflow in the
sea water acclimated mullet (Mugil capito). Immersion
of 4phiocephalus maculatus in fresh water containing
aspirin for 24 hours significantly lowered plasma
osmolality and plasma Na+ and C1- concentrations
(Woo et al., 1980). Horseman and Meier (1978) reported
similar findings in Fundulus grandis. These findings
strongly suggest that PGs participate in maintaining
nroner ionic balance in fish.
The subsequent investigations examined the function




Prostaglandins have a wide spectrum of activities
and individual compounds differ in their actions. Their
effects on cardiovascular system, metabolism and
osmoregulation have been described earlier. Besides,
other manifestations of prostaglandin effects on smooth
muscle are represented by their oxytocic actions on the
gravid uterus and by their abilities to stimulate intestina
motility. Prostaglandin effects on reproduction are
quite pronounced. High levels of prostaglandins are
associated with a breakdown of the corpus luteum and a
depression in progesterone secretion. They are also
implicated in the release of LH by mediating the release
of LRF in the hypothalamus. Prostaglandins are implicated
in the inflammatory responee, in various aspects of the
immune response, in the hematopoietic system, in gastro-
intestinal secretion, in bone resorption, in digestive
system, in respiratory system and n the central nervous
system, where certain PGs have been implicated as
neurotransmitters (further information, see Ramwell, 1973,
1974, 1977).
Perhaps the most important activity of prostaglandins
is their involvement with the actions of cAMP, the second
messenger in so many trophic hormone activities. This
is evidenced by the fact that PGs significantly increase
the tissue content of cAMP in many tissues and organs
including lung, spleen, diaphragm, blood platelets, liver,
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pituitary, aorta, bone, gastric mucosa, kidney, heart,




(I)DIsTRIBUTI0N OF PROSTAGLANDIN E IN THE TISSUES OF THE
SNA KE HEAD
(1) Introduction
The distribution of various prostaglandins in the
tissues of various animals has been reviewed (for details,
see pp. 26-31). Among the mammals, a comparison of the
distribution of different types of PGs shows that E series
of prostaglandin is the most abundant and is present in
almost every tissue. The existence of PGFa in the tissues
is less abundant and the amount of PGA and PGB in the tissues
are found to be least.
Due to the scarcity of information on the distribution
of prostaglandins in lower vertebrates (Ogata and Nomura,
1975 Nomura et al., 1973 Vogt et al.. 1967) and in
invertebrates (Nomura and Ogata, 1976 Weinheimer and
Spraggins, 1969), a comparison of the, distribution of PGs
cannot be stated. From all these reports on occurrence of
PGs in tissues of lower vertebrates and invertebrates,
PGEs are generally distributed in every tissue so. far
studied. PGFds are less commonly found in tissues. No
information about the existence of PGAs (except Gorgonian
has 15-epi-PGA2 and. its diester) and PGBs in the tissues of
lower animals has been published.
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In general, the amount of PGEs in the tissues varies
with the type of tissues (1 to 2000 ng/g of wet tissue,
except human semen: 38500 ng/g of wet tissue) (Nomura and
Ogata, 1976).
In fishes (Carp, sheat-fish and leopard shark),
the alimentary canal possesses a large amount of PGE
(75-1350 ng/g of wet tissue) when compared with other tissues
in the same fish. Heart, kidney, gill and air bladder also
have an abundant amount of PGE (100 to 500 ng/g of wet tissue)
Skeletal muscle, ovary, testis, fin and brain contain about
1 to 60 ng PGE/g of wet tissue (Nomura and Ogata, 1976).
It is well known that prostaglandins have an extensive
diversity of biological effects in mammals. However, their
physiological importance in lower animals has not been
reported. It is quite interesting to decipher this puzzle
in the comparative point of view. Therefore in the present
study, experiments designed to investigate the effects of
PGs in a lower vertebrates, the snakehead, were performed.
Before studying the effects of prostaglandins in the
snakehead, a confirmation of the occurrence of PGs in the
tissues of the snakehead seems to be necessary. Besides,
a study of the distribution of PGE in the snakehead will
at least indicate that PG may play a physiological role in
this animal. Such a study also provides more information
on the occurrence of PGs in lower vertebrate. Hence, the
present experiment was designed to investigate the possib?e
existence of PGs in the snakehead.
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(2) Materials and Methods
(a) The Experimental Animal
The snakehead fish, Ophiocephalus maculatus Lacepede
(Teleostei: Ophiocephalidae) was used in the present study.'
This fish is indigenous to South-East Asia, Ophiocephalidae
has a marked ability to withstand hypoxia and a high growth
rate (Chow et al., 1962 Hu and Chen, 1964). It is
carnivorous and inhabits ponds and rivers. It can also
tolerate a certain range of salinity change (from 1-450 mfOsm/
kg) (Tong, 1980).
In order to ensure that the same species of fish
(see Plate 1) was used in all of the experiments, a careful
identification of the snakehead has been undertaken.
It is known that different species of snakeheads have
different number of fin spines. The number of fin spines





A count of the number of spines in addition to the
general morphology of the fish contributes to the
identification work. The experimental animal in the present
study corresponds to the species Ophiocephalus maculatus
Lacepede reported by Ng and Kam (1977).
(b) Keeping of the Snakeheads in the Laboratory
Snakeheads were purchased from a local commercial
supplier and transported to the laboratory without
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Plate 1 Photograph of snakehead, Ophiocephalus
maculatus Lacepede,*
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anaesthetic. All snakeheads were adapted to fresh water
at 18-23°C without food for at least two weeks before
further treatment. Since it is known that body size of
fish affects the metabolic rate and other physiological
processes greatly (Chan and Woo, 1978), snakeheads with
similar size were chosen in order to eliminate the body
size effect. The body weights of the animals were in the
range of 110-140g.
(c) Sampling Techniques
Snakehead was sacrificed and the tail was cut and
the blood was collected from the exposed caudal vein as
quickly as possible. Heparinized microhematocrit tubes
were used to collect blood and then one of its end was
sealed. After centrifugation plasma was saved and then
frozen for later use.
Various organs including: liver, kidney, spleen,
gastrointestinal tract, epaxial muscle, urinary bladder,
heart and gill were removed from the fish. Then the gastro-
intestinal tract was placed in cold 0.9% NaCl for washing out
the food particles present in the tract. The tract was
then lightly blotted on filter paper. The whole liver was
removed and weighed. Muscle tissue samples were taken
from the left side below the dorsal fin of each fish.
Individual gills were removed by cutting through each gill
arch and washed in cold 0.9% NaCl and excess fluid removed.
Only gill filaments were saved for extraction of PGE.
Urinary bladder was collected and washed in the cold 0.9%
saline. All these tissues were subjected to homogenization
immediately after removal without freezing.
(d) Extraction, Separation and Measurement of Prostaglandins
(i) Extraction of prostaglandins
The present methods were modified after the guide
for the radioimmunoassay of prostaglandin E (Calbiochem).
For Tissue Sample
1. Tissues were homogenized (500-2000 mg) with glass
homogenizer in a 1 ml solution of 0,9% NaCl and
O.k ml 0.1 N HC1
2. The homogenate was transferred into an extraction
tube. The homogenizer was rinsed with 2.6 ml of
ethyl acetate (Unilab)isopropanol (Mallinckrodt)
(1:1 volvol) and added to the homogenate. The
tube was stoppered and shaken vigorously for 15 min
3. 3 ml of 0.9% saline and 2 ml ethyl acetate were
added and mixed well
4. The tube was centrifuged and the upper ethyl acetate
phase was saved
5. The upper ethyl acetate phase was evaporated under
a stream of air
For Plasma Sample
1. 3 ml of ethyl acetateisopranol0i1 N HC1 (3:3:1;
volvolvol) was added to 1 ml of plasma
2. The contents were shaken vigorously for 15 min
3. The procedure was repeated as from step 3 for
tissue sample
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(ii) Separation of Prostaglandins
This method also followed the guide for the
radioimmunoassay of prostaglandin E'(Calbiochem)
Solvents for PG-Separation
The four solvent mixtures listed below were used
for separation of PG's into subclasses. Reagent
grade benzene (Fisher), ethyl acetate (Unilab) and
methanol (Merck) were used for preparing the
separation mixtures. The nomenclature S-1, S-2,
S-3 and S-4 were used to denote the four solvent
mixtures as follows (Orczyk and Behrman, 1972):-




60:40:10 (vo l/vo l/vo l)
S-4: Benzene/Ethyl acetate/Methanol
60:40: 2 (vol/vol/vol)
Preparation and Use of Silicic Acid Columns
1. A 10 ml glass pipet was used for the preparation
of silicic acid column
2. A small plug of glass wool was inserted into the
tip of the pipet
3. For every 0.25 g silicic acid.(100 mesh, RG,
ref: FLUKA 60780), 1 ml S-1 was added. 2 ml of this
suspension was carefully added to the column
4. The column was allowed to drain. The following
solvents: 5 ml of S-2; 1 ml of S-1; 0.5 ml of S-1
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were successively added one by one and then
was allowed to drain
5 0.2 ml of S-2 was added to the evaporated crude
lipid extract and then 0.6 ml of S-1 was added,
This solution was carefully applied to the prepared
column with a Pasteur pipet
6. The column was allowed to drain, then eluted with
6 ml. of S-1. The fraction contained neutral
lipids, fatty acid, steroids, PGB and PGA
7. The column was then eluted with 12 ml of S-4.
This fraction contained PGE
8. The final elution was with 3 ml of S-2. This
fraction contained PGF
(iii) Measurement of PGEs
The fraction containing PGE was evaporated under
a stream of air. The quantity of PGE was estimated
by the colorimetric method based on the Zimmermann
reaction (Corker et al., 1962). This reaction is
based on the formation of a colored product by the
reaction of ketones with m-dinitrobenzene in alkaline
condition. Since PGEs also contain a ketone group
at carbon-9, therefore they react with
m-dinitrobenzene to form a colored product in alkaline
condition.
Solvents for PGEs assay
1. All components of the reaction mixture were made
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up of absolute ethanol (Unilab)
2. 2.5 N KOH in ethanol was stabilized with N2
3. 1% m-dinitrobenzene in absolute ethanol was
prepared
Procedure
1. 0.1 nil ethanol was added into the dry fraction
containing PGE
2. 0.3 ml of 1% m-dinitrobenzene in absolute ethanol
was added
3. The contents were mixed well and the tubes were
cooled to 0°C in an ice-salt bath
4. 0.3 ml of 2.5 N KOH was added and was immediately
mixed-by shaking briskly. Bright light was avoided
5. The tubes were stood in a covered ice-salt bath
for 20 min
6. The sample was diluted with 2.5 ml of cooled 80%
ethanol
7. The optical density.was read at 580 nm within a
10 min period
Standard curve of PGE
PGE1 (No. P-5515) was purchased from Sigma
Chemical company. PGE1 with amount of 2,4,10,20 pg
were used for preparing the standard'curve. PGE1 is
initially dissolved in ethanol (Unilab) (PGE1 is very
stable in ethanol and is storad at 0°C) and suitable
amount of PGE1 solution was taken and was evaporated
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to dryness. 0.1 ml of ethanol was added and colorimetric
determination of PGE1 processed as listed above.
Data are present as Means+ Standard Error of the
Mean (M± S.E.M.). Statistical analysis of the results
were carried out using Student's It test (Gray, 1971--).
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(3) Results
A standard curve of PGE1 was prepared (Fig. 9).
Since the result of standard curve of PGE1 could be
repeatable, it is quite reliable to use the colorimetric
method of Zimmermann reaction to estimate pure PGEs.
Other possible interfering substances in the assay
of PGEs were also tested (Table 5). The compounds included
cholesterol, cholecalciferol, palmitric acid, retinal
palmitate, vitamin E acetate, hydrocortisone (sodium
succinate), triolein and snakehead plasma lipid. Some of
these substances are commonly found in.various tissues and
most of them are soluble in organic solvent. Therefore
they may be present in the PGEs tissue and plasma
extracts and hence might interfere with the estimation of
PGEs in the colorimetric method. The amounts of these
substances used in the test were far more than the actual
quantity found in the tissues and plasma (Krupp et al.,MOWN
1979). Cholesterol (1.1+6 mg/3.2 ml), vitamin E acetate
(15mg/3.2 ml) and triolein (0.6 mg/3.2 ml) had absorbance
of 0.08, 0.015 and 0.035 repectively. Since the amounts
of these substances were much more than the actual
occurrence in the tissues and plasma, therefore, these
substance would not interfere with the present method for
assay of prostaglandin. Other compounds such as
cholecaliferol, palmitic acid, retinol palmitate,
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Fig.9 standard curve of PGE1 in Zimmermann reaction.
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Table 5. A summary of possible interfering substances in the assay
of prostaglandin (Zimmermann Reaction).











m-dinitrobenzene solution did not have any absorbance at
580 nm.
A recovery control of authentic PGE1 after running the
silicic acid column was done0 Recovery of PGE1 after the
column was found to be 42.7%.
Although the qualitative analysis of PGE was not
demonstrated in this experiment, the present result indicates
that PGE-like substances were found in the tissues and plasma
of snakehead. The occurrence of PGE-like substances in various
tissues of snakehead was listed in Table 6. The present result
shows that the comparatively significant amount of PGE-like
substances in each tissue and plasma. The concentrations of
PGE-like substances in yig/g of wet tissue were estimated and
PGE1 was used as standard. All the tissues in the present
study contain PGE-like substances. The concentration of PGE.-like
substances varies with different tissues and they were in the
range of 0.078 to 1.31 pg/g of wer tissue. It appears that
liver (1-31 )ag/g of wet tissue) and urinary bladder (1-154
Ong/g of wet tissue) are inclined to have a higher level of
PGE-like substances. Gill, Spleen, kidney, heart and plasma
have a moderate amount of PGE-like substances (0.117-0.167
ug/g of wet tissue) whereas muscle (0.078 ug/g of wet tissue)
and gastrointestinal tract (0.083 ug/g of wet tissue) contain
a significantly low concentration of PGE-like substances when
compared with the other tissues.




























The number in parenthesis represents the number of animalsc
The amount of PGE-like substance was estimated by usina PGE„ as standard.
All values had been corrected to 100% recovery by standard PGE recovery control.
The values are expressed in Mean+Standard error of the mean.
+ Gill filaments were pooled from six animals.
# The amount of PGE-like substance in plasma was expressed in pg PGEml.
96
(4) Discussion
The present extraction method has been well
established and widely used (Lijnen et l., 1979
Godard et l., 1976). Although a minor modification
involving the use of chloroform/methanol (2:1 by vol)
(Samuelsson, 1973 Ogata and Nomura, 1975) instead of ethyl
acetate/isopropanol (1:1 by vol) has been employed, there
is no change in the general extraction condition (acidified
to pH 3.0 with HC1 solution). Since PGs are very soluble
in organic solvent,_a change in organic solvent system will
not cause a-significant change in.-.extraction efficiency.
Therefore, the present extraction method provides a reliable
method for extraction of PGEs in plasma and tissues.
For the separation of PGs,-- silicic acid column
chromatography (SACC) and thin layer chromatography (TLC)
have gained popularity in the laboratory (Eastman and
Dowsett, 1976 Ogata and Nomura, 1975, 1976 Ogata et al.,
1978 Christ and van Dorp,* 1972 Caldwell et a1., 1971
Godard et al.,- 1976 Lijnen et 1., 1979). However, only
sil.icic acid column chromatography was employed in the
present study since there are many advantages to use SACC
instead of TLC. First of all, using.SACC consumes less
time in the separation procedure especially for analysis
of a great number of samples. Also SACC is a simpler
process than TLC and the running cost of SACC is less than
TLC. Besides. similar, recovery. for the separation of PGs
were reported for both TLC and SACC. Hence, SACC is
preferred in this study.
Recovery control of PGE after silicic acid column
chromatography was done. The recovery after the extraction
and separation procedure is 42.7% The recovery in this
study shows a good agreement with the recovery (42.08%) of
William's experiment (1971) using the silicic acid column
chromatography for separation of PGE•
From the standard curve of PGE (Fig. 9, p. 92)
only more than 7 of PGE in the assay sample would
reliably be determined. Therefore, it is better to use
the other methods such as radioimmunoassay, or mass
spectrophotometry rather than Zimmermann reaction method.
However, those methods require sophisticated techniques and
are time consuming. Ultra violet spectrometry is also not
a very sensitive method to measure PGE. Also the present
assay method cannot differentiate different types of PGEs
and all types of PGEs are detected by present method.
Moreover, the formation of colored product in the
Zimmermann reaction depends on the amount of substances which
contain a ketone group in their configuration. However
silicic acid column chromatography can provide a good
technique to purify PGE from the other lipid and fatty acid.
Therefore, the substance detected by the Zimmermann reaction
in the present study is PGE. Furthermore, PGFs, PGAs and PGBs
have not been estimated in this experiment. Since PGAs
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and PGBs are eluted in the same fraction in silicic acid
column chromatography method, a further separation is
required before assaying these compounds. In addition,
PGFs, PGAs and PGBs can only be detected by radioimmunoassay
and mass speetrophotometry. These methods require
sophisticated techniques and hence these compounds have
not been measured. Furthermore, the main purpose of present
experiment is to elucidate the occurrence of PGE-like
substances in the snakehead and the Zimmermann reaction
method provides a convenient assay for this purpose.
The distribution of PGE-.like substances in the snake-
head was listed in Table 6. All the tissues and plasma
studied contained PGE-like substances. When compared with
other fish species, such as carp, sheat-fish, leopard shark
(Nomura and Ogata, 1976) the amounts of PGE-like substances
in the tissues of the snakeheads are much higher. This is
possibly due to the low sensitivity of the present method.
However, the amount of PGE-like substances in gill and
gastrointestinal tract of the snakehead had similar
content as the carp, sheat-fish and leopard shark (Nomura
and Ogata, 1976).
The existence of high concentration of PGE-like sub-
stances in urinary bladder suggests that PGE may be involved
in biological functions in the urinary bladder (Lipson et
a1., 1971). It has already been shown that in the toad
urinary bladder, PGE1 inhibits vasopressin-induced water
transport by inhibition of adenyl cyclase activity (Orloff
et 1.,1965).
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It is tempting to speculate that the regulation of ion and/
or water transport by PGs is a more general phenomenon,
in view of the high PG synthetase activity found in gills
of fishes, mollusca and arthopoda and in frog urinary
bladder and mammalian renal medullar tissue (Chirst and
van Dorp, 1972).
The variable levels of PGE-like substances in different
tissues of the snakeheads indicates that a relative importance
of PGE in biological functions in these tissues. High amount
of PGE-like substances in liver suggests PGEs may play an
important role in the physiology of liver and it is proposed
that these compounds may regulate glycogen metabolism in liver.
Many reports have been published to show that PGs are involved
in the metabolic processes (Curnow and Nuttall, 1972 Exton
et al., 1971 Levine and Schwartzel, 1980). Therefore, in
this study, metabolic effects of PGs in snakeheads were
investigated in later experiments.
The present finding of the occurrence of PGE-like substances
in gastrointestinal tract is in accordance with the report
that PGs synthetase activity was found in carp intestine
(Christ and van Dorp, 1972; Ogata and Nomura, 1975). Since
PGs also exist in lower vertebrates, it is thought that PGs
have some physiological significance in the smooth muscle
motility of lower vertebrates as well as higher vertebrates.
Furthermore, the present data show that PGEs are
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found in kidney, gill, urinary bladder and gastrointestinal
tract of the snakehead. These organs have been reported
to be involved in the osmoregulatory processes in fish
(Conte, 1969). The existence of PGE-like substance's in these
may indicate the possible participation of prostaglandins
in osmoregulation of the snakeheads. It has been reported
that renal PGs formation is affected by NaCl uptake in
rabbit (Weber et al., 1979). This suggests renal PGs may be
involved in saltAwater regulation. When the gill tissue
of a marine bivalve, Modiolus demissus was incubated in
hyposmotic solution, a significant increase PGEs synthesis
was observed (Freas and Grollman, 1980). This result
suggests that PGE synthesis in the gill is dependent on
ambient osmolarity. In addition, Horseman and Meier (1978)
reported that some actions of prolactin with regard to
teleostean osmoregulation are mediated by stimulation of
prostaglandin synthesis.
Therefore, in subsequent experiments, the possibility
of the involvement of PGs in osmoregulation of snakehead
was investigated. The approach was to measure plasma ions
levels in the snakeheads after PGs injection and aspirin
treatment (PGs synthesis inhibitor).
In the present experiment, other types of PGs in
the tissues have not been estimated and further studies
should be pursuedo.
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II) CARDIOVASCULAR EFFECTS OF PROSTAGLANDINS
(1) Introduction
A wide spectrum of physiological and pharmacological
actions of prostaglandins-in mammals have been well
documented Since the first discovered effect of
prostaglandins was found to be their blood pressure lowering
property, hence, many reports on the cardiovascular effects
of prostaglandins have been published (for details, see
also Literature Review, pp. 41053). Generally, PGEs
exhibit a blood pressure lowering action and is accompanied
by positive chronotropic and inotropic effects. PGA and
PGB also decrease blood pressure in animals whereas PGF
elicits an animal-dependent cardiovascular response. As
well as PGs, their precusors such as arachidonic acid also
depresses blood pressure in animals.
However, these studies of prostaglandins effects on
the cardiovascular system were mainly carried out in mammals.
The author has-conducted a literature survey on the topic
and found that similar reports on lower vertebrates are lacking
(except Peyraud-Waitzenegger et al., 1974, 1975 Leffler
et al., 1980 Chiu and Leung, unpublished, 1980). Therefore,
the present experiments were attempted to elucidate whether
the cardiovascular responses to prestaglandins in snakehead
is similar to those in mammals. Studies of the effects of
PGA1, PGB1, PGE1, PGF1, as well as their precursor,
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arachidonic acid, on blood pressure in snakehead were
carried out. Breathing rate, heart rate and oxygen
consumption were also measured in these studies. Moreover,
possible interactions between prosta landins and g some drugs
such as indomethacin (PG synthesis inhibitor), reserpine
(c(-adrenergic receptor blocker) and pentolinium tartrate
(sympathatic and parasympathetic ganglionic blocker) were
also investigated.
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(2) Materials and Methods
(a) Experimental Animal
Snakeheads were purchased from a local commerical
supplier and kept as previously described (pp. 83-85).
Fish with body weights between 190-240 g were chosen in
these experiments. They were kept in freshwater at
20-25°C without food for 2 weeks before experimentation.,
(b) Surgery
(i) Catheterization of the gonadal vein
Snakehead was anaethetized by total immersion in
a MS-222 (triacaine methanesulfonate, Sandoz) solution.
While the snakehead was still anaesthetized, the
abodminal body wall of the animal was cut open and the
incision was kept open by a pair of retractors (Plate 2).
The gonadal vein was exposed by clearing the adherent
fatty tissues. The vein was tied'distally with a piece
of surgical thead and clamped proximally with a bulldog
clip. A PE-10 (Intramedic Polyethylene Tubing,
Clay Adams) cannula tube filled with heparinized isotonic
saline (0.9% NaC1) was inserted through a puncture into
the gonadal vein and the tube was tightly fastened in
place. The gonadal vein was .unclamped.
Catheterization of pneumogastric artery
After the catheterization of the gonadal vein,
the pneumogastric artery was also cannulated by
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Plate 2 Cannulation of the gonadal vein. The
abdominal body wall of snakehead was cut
open and the incision was kept open by a
pair of retractors.
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inserting a PE-60 (Clay Adams) polyethylene tube
(Plate 3) as described above. The body wall was
sutured up with silk thread and the fish was then
returned to a black respirometer containing 3,
litres of well aerated fresh water. The fish was
allowed to recover from anaesthesia without
disturbance.
(c) Injection of Prostaglandins
After recovery for two hours from anaesthesia,
different types of prostaglandins was injected separately
into the fish through the gonadal vein cannula. Different
doses of PGA1, PGB1, PGE1, PGF1 and arachidonic acid
(5, 159 30 and 60 )ug/kg, of body weight) were, injected
intravenously. Before injection, suitable amounts of
prostaglandins (Upjohn) and arachidonic acid (Sigma)
(dissolved in absolute ethanol 0.5 mg/fnl) was diluted
five fold with 0.9% NaCl. Injections of appropriate
amounts of ethanol and 0.9% NaCl served as controls.
(d) Recording of Blood Pressure
Before and after the injection of PGs and arachidonic
acid, the arterial blood pressure of the fish was measured
through the pneumogastric artery cannula by means of a
pressure transducer (Harvard Apparatus) connected to a
series of amplifiers (Harvard Apparatus) and the final
output was displayed on a Harvard Biograph System.
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P late 3 C atheterizationof pneumogastricartery .
T he abdominal body wall of snakehead was
cut open and the incision was kept open
by a pair of retractors.
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( e ) C ountingof H eart B eat and B reathingR ate
T he heart rate of snakehead were estimated by the
number of pen deflection of the blood pressure tracing .
B reathing rate was estimated by counting the number of
opercular movements .
( f ) M easurementof O xygen C onsumptionR ate
T he oxygen consumption rate of snakehead was measured
by following the rate of oxygen depletion in a closed
chamber . P olyethylene container ( 3 litre ) with removable
lid served as the respiratory chamber . B efore measurement,
the fish was kept in the respiratory chamber ( fresh water )
at a constanttemperature2 0 ± 1 o C for two hours to allow
it to adapt to the surroundings. T he water was well
aerated during the period . T he chamber was then filled
with water and the experiment started by removing aeration .
T he water inside the respirometerwas mixed using a
varistalticpump ( M anostatic, A dvance M odel ) . T he decline
in p 0 2 of the water was continuouslymonitoredusing a
G ilson oxygraph system coupled to an oxygen electrode
( Y ellow S tone I nstruments) .
( g ) I njection of drugs : I ndomethacin, R eserpineand
P entolinium tartrate
R eserpine , pentolinium tartrate and indomethacin
were purchasedfrom ( S igma ) . R eserpine and pentolinium
tartrate were dissolvedin 0 . 9 % N a C l and indomethacinwas
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suspend in the 0.9% saline. Indomethacin (10 mg/kg of
body weight), reserpine (0.5 mg/kg) and pentolinium
tartrate (5 mg/kg) were injected intra-peritoneally into
the fish daily for 3 consecutive days. A fourth dose was
injected just before surgery. The cannulation procedure




(a) Effects of Prostaglandins and Arachidonic acid on
Blood Pressure
The basal arterial blood pressure of snakehead is
20.5±1. O mmHg. Injection of ethanol (diluted to five fold
with 0.9% NaCl) as a control into the fish produced no
change in arterial blood pressure (Fig. 10) PGE1 and
PGA1 elicited a dose-dependent decrease in arterial
pressure (Fig. 11).PGE1 was more potent than PGA1 in
lowering arterial pressure. On the contrary, PGB1 elevated
the arterial pressure, in a dose-dependent manner in
snakeheads (Fig. 11). The minimum dose of producing blood
pressure effects of PGA1, PGB1 and PGE1 are approximately
equal to 2ug/kg of body weight. Hence the doses which
are below 2,ug/kg cannot produce any effects on blood
pressure in snakehead. Also the effects of the three PGs
reach the plateau at.dose .90 ug/kg (Fig. 10, PGA1 injection
with 90 and 1 20 /ug/kg), therefore, higher doses cannot
exert a stronger action on blood pressure.
The most striking finding was that PGF1,, and arachidonic
acid produced no response on arterial blood pressure in
snakeheads (Fig. 10) regardless of the dose. These results
are in contrast to those reported on mammals (for details,
see also pp. 59-60).
A plot of the time course of changes in arterial





PGE1 15ug/kg PGE1 5ug/kg PGE1 60ug/kg
PGA1 120ug/kg PGA1 90ug/kg
PGA1 30ug/kg PGA1 15ug/kg
PGB1 15ug/kg PGB1 30ug/kg
MINUTES
8. 10 Effects of intravenous injection of arachidonic acid
(AA), PGs and ethanol (ETOH) in arterial blood
pressure of snakeheads. The blood pressure was
measured through the pneumogastric artery cannula.


















Fig 11 Dose-dependent responses to PGA, PGE and PGB
in arterial blood pressure of snakeheads Date
were expressed in the Mean+SEM n denotes the
number of fish
Fig. 12 Effect of intravenous injection of PGB.
in arterial blood pressure of five
snakeheads. Each symbol denotes the
Mean and SEM
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After PGB1 injection, an immediate and prompt increase
in arterial pressure was observed. This increase reached
its peak about 2 minutes after receiving PGB1 and was
followed by a gradual and prolonged decrease which returned
to normal after 20 minutes.
PGE1-induced decrease in blood pressure reached
maximum 5 min after injection and then the blood pressure
gradually returned to normal (Fig. 13). After the injection
PGA1, the blood pressure reached the maximum 1.8 min after
injection (Fig. 14). This increase in blood pressure was
found to occur more quickly than PGE1 effect.
(b) Effects of Prostaglandins and Arachidonic acid
on Heart Beat and Breathing Rate
The basal heart beat and breathing rate were 42±6
beat /min and 25±3 beat /min respectively. Prostaglandins
and arachidonic acid did not produce any chronotropic
effect or alt6r breathing rate of snakeheads.
(c) Effects of Drugs on Blood Pressure
Four daily intraperitoneal injections of indomethacin
(10 mg/kg) and pentolium tartrate (5 mg/kg) significantly
lowered the blood pressure when compared with their
corresponding controls (Fig. 15), However, reserpine
(0.5 mg/kg) did not change the basal blood pressure
(Fig. 15).
When snakehead received pentolinium tartrate
Fig. 13 Effect of PGE injection in arterial blood
pressure of six snakebeads Each symbol
denotes tbe Mean and SEM
TIME AFTER INJECTION (MIN)
Fig. 14 Effect of PGA1 in arterial blood pressure
of five snakeweeds Each symbol denotes
the Mean and SEM
Fiar. 15 Arterial blood pressure in snakeheads
after indomethacin (IN), pentolinium
tartrate (P) and reserpine (R) treatment
Results were expressed in the Mean and SEM,
C=contol. Number in parenthesis represents
the number of fish P005 when compared
with controls.
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(ganglionic blocker) treatment, the PGA1- induced hypotensive
effect was partially abolished (Table 7). Moreover,
pentolinium tartrate also partially reduced the pressor
response to high dose of PGB1 (00,iug/kg), whereas no effect
could be observed on the response to low dose of PGB1
(30 /ug/kg). On the other hand, pentolinium tartrate did
not alter the PGE14 induced decrease in arterial pressure.
Reserpine has been found to be an antihypertensive
drug. In this experiment, r©serpine did not change the
pressor effect induced by PGB1 at high dose (60 /ug/kg) or
low dose (30 /ug/kg).
(d) Effects on Oxygen Consumption Rate by PGEs
Control injection (Ethanol: 0.9% NaCl 1:4 by vol)
did not change the oxygen consumption rate of snakehead,
whereas 10 min after intravenous injection of PGE1
(30/ug/kg), a statistically significant decrease in oxygen
consumption rate (Fig. 16) was observed. This PGE1-induced
decrease in 02 consumption rate gradually returned to
pre-injection level after 3 hours.
able 7 5 Effects of PGs injection in arterial blood
pressure on snakeheads












































































N=number of fish ; A.B.P,=arterial blood pressure
S.D.=statistical significant difference
i.p.=intraperitoneal injection ; i.v.=intravenous injection






0 40 60 130 150
TIME AFTER INJECTION (min)
Saline
PGE1
Fig. 16 Effect of intravenous injection of PGE (30
in O consumption of five snak@fa.eads Appropriate
amount of e t fa a no 1 4- saline was injected into the
fish as controls® Results were expressed in Mean
SEM. P 0o05 when compared with controls,,
(0 Discussion
The present results strongly suggest that
prostaglandins exert cardiovascular effects on snakeheads»
However, only PGA.J, PGB and PGE had profound vascular
actions in snakeheads, while PGF., and arachidonic acid
did not alter the arterial blood pressure®
PGA and PGE both decreased the arterial blood
pressure in snakeheads® These results are in agreenant
with those effects found in mammals (Holmes ejt al., 1963;
Horton and Jones, 1969; Weeks ert al®, 1969$ Carlson et al•,
1969, Greenberg ei; ai®, 1975 Chappie et al®, 1980).
Administration of Prociuced depression of arterial
pressure in bullfrog (Leffler et al®, 1980) and in carp
(Cyprinus carpio) (Peyraud-Waitzenegger ejb al®, 1975
1975) The effects of PGE-induced decrease in arterial
blood pressure in snakeheads is in accordance with those
effects on carp®
However, the mechanism of action of the hypotensive
effect of PGA„ and PGE. in snakehead has not been
investigated in this experiment. In mammals, the hypotensive
effect of PGAs and PGEs are most likely due to marked
dilatation of peripheral vasculature resulting in a decrease
in total peripheral resistance (Horton and Jones, 1969;
Weeks et al®, 1969; Saunders and Moser, 1972; Hovenaghel
et al®. 1979)« In frog kidney perfusion, PGE1 has been
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shown to increase perfusion rate (Chin and Leung,
unpublished). Therefore, it is suggested that PGA1-and
PGE1-induced hypotensive effect in snakeheads may also
be caused by a decrease in total peripheral resistance
in this fish.
Prostaglandin Bs are formed from prostaglandin A by
the action of a prostaglandin isomerase which is present
in plasma (Jones t 1972 Jones and Camniock, 1973)- PGAs
and PGBs both have similar structure except' the location
of double bond in the ring (for details, see also ip. 14).
Due to the similarity of these two compounds, they both
exert similar actions on cardiovascular system. It has
been published that PGA1 and PGB1 both have vasodepressor
potencies in mammals (Jones, 1972 Greenberg et al., 1973).
Furthermore, the vasodepressor action of PGBs is less potent
than PGAs. However, the present finding in snakehead is
in discordance with those found in mammals. PGB1 induced
vaso0opressor effect in snakehead instead of vasodepressor
action. The present experiment cannot explain this aberrant
result of PGB1 in snakehead.
The cardiovascular effects of PGFSIs and arachidonic
acid in mammals have been previously described in pp. 59-63.
Ghiu and Leung ('unpublished) showed that PGF1., constricted
renal vascular system to reduce the perfusion rate in frog
kidney perfusion. However, Leffler et al. (1980) showed
that PGF and arachidonic acid decreased arterial pressure 2ol
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in bullfrog. In this study, however, both PGF s and
arachidonic acid had no effect on cardiovascular system
in snakeheads. Moreover, the cardiovascular effects of
arachidonic acid in mammals and bullfrog is mediated by
biotransformation'to active PGs (since indomethacin abolished
all of the cardiovascular effects of arachidonic acid)
(Okuno et a1., 1980 Damas and Volon, 1978 Leffler et a1,
1980). Due to no observable arachidonic acid-induced
cardiovascular effects in snakeheads, arachidonic acid may
not be converted immediately to an active PG(s) in the
vascular system of snakeheads. The inability to synthesize
PG(s) from arachidonic acid may be caused by low biosynthetic
activity of PGs in the vascular system or lack of PGs
synthesis enzymes. The,latter possibility is eliminated
by the result obtained from indomethacin-treated fish
since indomethacin significantly decreased the basal
arterial blood pressure in snakeheads. Although this
indomethacin-induced decrease was only one fifth of the
basal arterial pressure, the endogenous prostaglandins seem
to play a role in direct regulation of systemic blood
pressure in this fish. Hence, this indicates the existence
of prostaglandin biosynthesis enzymes in the vascular
system of snakeheads.
When compared with the dosage of PGs which can
produce cardiovascular effects in mammals, snakeheads seem
to require a much higher dose to produce the same effects.
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Whereas a dose of PGE1 (0.1 /ug/kg) can induce vasodepressor
effect in mammals q a minimal dose of 2 dug PGE1 /kg is
required to produce the same effects in snakeheads.
Moreover, a high dose of PGE2 (about 9.,ug/kg) is required
to induce a measurable decrease in blood pressure of bullfrog
(Leffler 'et al. 1980). It has been reported that the
metabolic rate of poikilothermic animal increases as the
ambient temperature increases (Bartholomew, 1977). Hence
the mammals have a higher metabolic rate than in
poikilothermic fish (acclimated at 20°C). Therefore, in
snakehead, the higher doses of PGs required to elicit
effects can be explained by a lower metabolic rate in this
fish.
In addition to the low body temperature in snakeheads,
a long biological half life of PGs in snakehead also
indicate a low metabolic rate in this fish. The biological
half life of prostaglandins in snakehead can be shown by
the long duration of the vasodepressor or Vasopressor
actions. In- dog, only 3 min was required to recover from
the PGE (11 Jug/kg)-induced hypotensive effect (Nakano and
1
McCurdy, 1967) whereas a similar fall in blood pressure in
bullfrog required 7 min to recover (Leffler et 1.. 1980)
Moreover, the present results showed that snakeheads
required 20 min to recover from the effect. As well as
PGE1, PGA1-and PGB1 also produced long duration vasoactive
effects in the fish. Therefore, this suggests a long
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biological half life of PGs in snakehead. In mammals p
90% of PGE1 was inactivated after one single passage through
the pulmonary circulation (Ferreira and Vane, 1967). In
contrast, the biological effects of infused PGA1 and PGA2
were not lost after one passage through the lungs of dog
and cat (McGill et ale p 1969 Horton and Jones, 1969).
suggesting that PGAs may act as circulating hormones.
However, the possible ways of inactivation of prostaglandins
in fish have not been reported and cannot be demonstrated
in the present experiment. Further studies should be
required in order to decipher this problem. `Moreover, the
long biological half life may be due to the intrinsic
property of snakehead and or low metabolic rate. Of course,,
the long duration effects can also be explained by a
prolonged action of the activated PG receptors. Such a
proposal-of course requires further experimental evidence.
The PGE-induced decrease in blood pressure was
accompanied by positive chronotropic and inotropic effects
in dog (Nakano and McCurdy, 1967). However, the'present
results show the contrary, PGE1 exerted no effect on the
heart beat in fish. Moreover, the present experiment
cannot demonstrate the possible effect of PGE1 on cardiac
contractility. Moreover, Peyraud-Waitzenegger et l.,
1974 1975) studied the effect of PGE2 in carp. They showed
that PGE2 induced a prolonged- depression of arterial pressure
associated with an initial bradycardia followed by
tachycardia-,. Efferent vagal blockade by atropine or bilateral
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section of cardiac branches of vagus prevents the initial
bradycardia and the correlative drop in arterial pressure.
Nevertheless,, the prolonged vasodepressor effect was not
abolished. This suggests that the hypotensive effect
caused by PGE2 seems to result from 2 components:
(1) an indirect action mediated by vagus (2) direct action
on smooth vascular muscle.
Pentolinium tartrate has been reported to have the
inhibitory effects on both sympathetic and parasympathetic
ganglia (Meyer et al., 1972). Its mechanism of action is
to prevent depolarization of the postsynaptic membrane of
the postganglionic fiber. Therefore the fish treated with
pentolinium tartrate exhibited a decline in ganglionic
activation and hypotension. However, in snakeheads,
ganglionic blockade (pentolinium tartrate) did not reduce
the PGE1-induced hypotension. This shows that PGE1-induced
vasodepressor effect is not mediated through the autonomic
nervous system. From other reports (see also -.!p. 56),
we can conclude that vasodilation and the associated
decrease in arterial blood pressure produced by PGEs was
not mediated through cholinergic mechanism, release of
histamine, stimulation of 13 -adrenergic receptors or through
blockade of a -adrrenergic receptors. Furthermore,
pentolinium tartrate can partially abolish PGA1 vasodepressor
effect. This suggests ganglionic activation may be at
least involved in the hypotensive action induced by PGA1
in the snakeheads. Pentolinium tartrate also partially
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abolished the PGB1-induced hypertension while reserpine
did not modify the vasopressor action of PGB1.- This
indicates that PGB1-induced vasopressor effect is independent
of the cholinergeric elements but at least ganglionic
components are involved.
From these results, it can be inferred that the
vascular effects of PGA 1, PGE, and PGB1 are mediated
through different mechanisms in the snakehead. In order
to clarify these mechanisms, detail studies are required.
There is considerable evidence to suggest that the
diverse actions of prostaglandins are mediated by inter.
action with different receptor types. However, pharmacologists
do not at present talk in terms of named receptors since
the specific receptor antagonists, essential to this approach,
are not as yet available. In addition, the sheep arterial
system has been reported to contain a PGE2-sensitive
receptor mediating vasodilation (Jones, 1976). Fat cell
and corpus luteum have been shown to have PGE-sensitive
receptor (mediating antilipolytic action) (Kuehl et al.,
1973) and PGF2 -sensitive binding receptor (Powell et al.,
1974) respectively. These receptors have been found to
have different relative dissociation constants for the
binding of different prostaglandins (Jones, 1976). From
the previous paragraphs, the findings of cardiovascular
effects of PGA1, PGE1 and PGB1 suggest that they seem to
have pro4taglandin receptors in the vascular system of this
fish Evenmore, they each may have their independent
receptors in snakehead
In carp, hyperventilation caused by was °kservec
(Peyraud-Waitzenegger e_t al, 1975) However no observable
hyperventilation can be induced by PGE, PGA and PGB in
snakeheads.
Besides the vasodepressor effect induced by PGE,
a decrease in consumption rate after intravenous injection
of PGE was demonstrated A statistical significant decrease
in O consumption rate was found only at about 10-15 min
after injection of PGE. An alteration of oxygen consumption
may result from change(s) in heart rate, stroke volume, gill
vasculature and metabolic necessity (Bartholomew, 1977)
In the present results, no PGE-induced change in heart
rate was observed, hence this eliminates the possible
contribution of heart rate in decrease in 0 consumption.
Since many reports have been published that PGE can
significantly increase stroke volume and cardiac output
in dogs and rats (Weeks ert al., 1969; Carlson ejfc al, 1969;
Maxwell, 1967), therefore, PGE-induced decrease in 0
consumption rate is unlikely due to a decrease in stroke
volume and cardiac output in snakehead. Moreover, PGE
has been reported to decrease peripheral vascular resistance
in mammals (see also pp. 5-55) therefore a decrease in
consumption may not presumably be caused by a decrease
of gill vascular resistance in snakehead. The last factor
involved in a change in 0 consumption rate is the metabolic
requirement. Therefore, subsequent experiments were designed
to investigate the possible involvement of prostaglandins
on the metabolism of snakehead (for detail, see alqo
PP. 129-195)
In the present experiments, the dose applied to
snakeheads were very high, it ranged from 5 pgkg to
60 pgkg of prostaglandins. They are presumably within
the pharmacological range rather than physiological doses.
Such high doses were used because at least 2 jigkg of
prostaglandins is required to induce measurable cardiovascular
effects in snakehead. This phenomenon may be due to the
low basal blood pressure and low basal metabolic rate or
can be an intrinsic property of the snakeheads. Although
high doses of PGs are required to elicit blood pressure
changes in the snakehead, the observation that indomethacin
treatment (PG synthesis blocker) lowers basal blood pressure
indicates an involvement of PGs in the control of normal
vascular function.
(III)METABOLIC EFFECTS OF PROSTAGLANDINS
(1) Introduction
The actions of PGE on glucose metabolism have been
well decumented. In in vivo studies injection of PGE
produced hyperglycemia and decreased plasma FFA level
in mammals (Berti et al., 1965; 1967; Sacca et al., 1973)
and goose (Grande and Prigge, 1972). In experiments
on incubation of liver slices with PGE, a decrease in
glycogen level was observed (Bohle and May, 1967).
Furthermore, Lemberg et al.. (1971) reported that PGE
infusion induced a significant increment in the average
glucose levels in the perfusate of the isolated perfused
rat liver. Also two glucose metabolic key enzymes
(glycogen synthetase and glycogen phosphorylase) activities
in liver were altered by PGE and increased glucose release
(Curnow and Nuttall, 1972). On the contrary, Exton et al.
(1971) and Levine (1974; 1979) showed that PGE1 and POE
perfusion in rat liver failed to alter cAMP and glucose
production.
Besides the actions on glucose metabolism, PGs have
also been shown to affect lipid metabolism. Steinberg et al.
(1964) showed that PGE reduced basal lipolysis in pieces
of epididymal adipose tissue. Butcher et, al. (1967, 1968)
suggested that antilipolysis action of PGE was associated
with formation of cAMP which in turn activated intracellular
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triglyceride lipase.
Although the metabolic effects of prostaglandins
have been studied extensively,these experiments only
focused on mammalian systems. The metabolic effects of
prostaglandins'in lower animals have never been published
before. Therefore the present experiments attempted to
investigate the metabolic effects of prostaglandins in
snakeheads. Besides, a comparative study of the effects
of PGA1, PGB1, PGE1, PGF1x, and PGs precursor, arachidonic
acid on metabolism were also carried out in the present
experiments.
The effects of intraperitoneal injection of PGs
and arachidonic acid on plasma metabolites: glucose,
lipid, free fatty acid and protein (total, albumin and
globulin) levels and liver glycogen and some liver
enzymes were studied. Plasma Na+ K+, osmolality and
hematocrit were also measured after PGs injection.
PGE1 has been well known to have pronounced
metabolic effects. Hence, an experiment involving
intravenous injection of PGE1 was undertaken and plasma
metabolites were estimated. This provided more evidence
on the metabolic effects of PGE1.
Since the metabolic studies of exogenous
Prostaglandins have been established, a possible effect
of endogenous Prostaglandins in metabolism is indicated.
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I n order to elucidate the possibilities of endogenous
PG s involvementsin metabolic control , a PG s biosynthetic
blocker - aspirin was employed in snakeheads. T he plasma
and liver metabolites were measured after aspirin
treatment and PGE 1 injection in aspirin treated fish .
(2) In vivo studies
3• Materials and Methods
(a) Experimental Animals
Snakeheads were bought from a local supplier and
transported to the laboratory without anaesthesia.
Fish were kept in plastic tanks with fresh water
(20-23°C)c They were unfed for at least two weeks
before experimentation. Fish with weight 100-l40g were
chosen for the present studies.
(b) Preparation of Prostaglandins Solution
PGA1, PGB1, PGE1, PF10( were gifts from
Dr. John E. Pike (Upjohn Company, Kamalazoo) and
arachidonic acid was purchased from Sigma Company.
Prostaglandins and arachidonic acid were dissolved in
absolute ethanol (0.5 mgml) and the solutions were
stored in refrigerator at 4°C. PG solutionswere warmed
up to room temperature before injection.
(c) Intraperitoneal Injection of Prostaglandins and
Sampling techniques
Prostaglandin in ethanol solution was injected
intraperitoneally into the fish and the dose used in
this experiment was uniformly 0.75 mgkg of body weight.
A control experiment was undertaken by intraperitoneal
injection of ethanol (1.5 mlkg). The fish were killed
at zero time, 30, 60, 120 and 180 min after injection.
The caudal vertebral column was cut and blood was
collected immediately from caudal artery by heparinized
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microhematocrit tubes( Dade). Then the microhematocrit
tubes were centrifuged and then hematocrit was measured.
The plasma was separated from the packed blood cells
and was collected in a plastic vial. The plasma was
frozen for later determination of plasma osomlality
and other parameters.
The whole liver was amputated and wrapped with
parafilm and then was stored in the freezer for later
analysis.
(d) Intravenous Injection of Prostaglandin E and
Sampling techniques
In some experiments, the pneumogastric artery and
gonadal vein were cannulated (methods as previous
described, pp. 103-105). After surgery, fish were allowed
to recover in a respiratory chamber for 2 hours before
injection. PGE1 (30 jig/kg) was prepared as previous
described ('p. 105) and was injected intravenously.
Then the blood samples were collected through the arterial
'annuls with heparinized microhematocrit tubes at 15, 30,
60, 120 and 180 min after injection. Before PGE1 injection,
an*appropriate volume of ethanol-saline mixture was injected
as controls. Then two blood samples were collected at
30 and 60 min'after vehicle injection. Hematocrit value,
plasma glucose and protein were determined as previously
described.
(©) Aspirin Treatment
In some experiments, aspirin (acetylsalicyclic
acid, Sigma) was used to block the biosynthesis of
prostaglandin in snakeheads. The fish were kept in
aspirin solution (lg251 freshwater) for 2k hours before
receiving PGE (0®75 mgkg)® All aspirin-treated fish
were sacrificed 2 hours after injection® The plasma
and liver were sampled as previously described®
(f) Plasma Composition Analysis
(i) Plasma osmolality
Plasma osmolality expressed in mOsmkg, was
measured in 50 plasma samples by determining the
freezing point depression in a Knauer Osmometer®
(ii) Plasma glucose
Plasma glucose was determined by coupled glucose
oxidase-peroxidase reaction (Sigma Technical Bulletin
No®510). As the plasma contains considerable amounts
of protein which will interfere with the reaction,
the plasma was first deproteinized by adding 0.3N
Ba(0H)20®3N ZnS0-7H20
(iii) Plasma protein (Total, albumin and globulin)
The total plasma protein was estimated by the
modified Lowry e_t al. method according to Hartree(1972)•
The reagents used were as following:
a® Standard solution: Bovine Serum Albumin (2mgml)
b. Solution A: 2g potassium sodium tartrate and
100g NaCO were dissolved in 500ral
1N NaOH and diluted with distilled water
to 1 litre
c. Solution B: 2g potassium sodium tartrate and 1g
CuSOHO are dissolved in 90ml distilled
water and 19ml 1N NaOH was added
d. Solution C: 1 volume Folin-Ciocalteu reagent (Merck)
was diluted with 15 volume water. This
solution must be freshly prepared©
Xn this test, a micromodification was employed,,
51 plasma was diluted with 1 ml of distilled HO. Then
0o9ml of solution A was added. The content was heated
in water both at 50°C for 10 min. Then it was cooled
to room temperature. 0.1ml of solution B was added and
standed for at least 10 min. 3ml of solution C was
injected into the sample and was immediately mixed
throughly. The content was then placed in 50°C water
for 10 min. After cooling to room temperature, the optical
density was read at 650 nm.
Plasma albumin and globulin levels were measured
according to the Sigma Technical Bulletins No, 630 and
560 respectively.
(iv) Plasma (-amino acids (FAA)
The concentration of plasma free -amino acids
was determined by the method of Mathews ej; al. (194)
with micromodification. In the present study, all reagents
and samples were scaled down by a factor of 3« The
optical density was read at 570 nra.
(v) Plasma total lipid
Method of Woodman and Price (1972) was employed
for the determination of plasma total lipid. 190 jul of
distilled water was added to 10 jiX plasma sample. Then,
1 ml concentrated HSO was ad-ded into this diluant
Then the content was boiled in water both for 20 min®
After cooling, 2ml color reagent (6gm anhydrous KHPOh-
0.3g vanillin +100ml HO; freshly prepared). The
content was read exactly after 10 min at 530 nm against
reagent blank. The standard was prepared by extraction
of snakehead plasma lipid using petroleum spirit,
(vi) Plasma free fatty acids (FFA)
Plasma free fatty acids was determined by method
of Pinelli (1973)• In this test, a micromodification
was used. The volumes of sample and reagents were
scaled down to a factor of 5. Zinc dibenzyldithio-
carbamate was used as color reagent and was read at kbO nm0
(vii) Plasma K+, Na+, Mg++and Ca++ levels
Plasma K+ and Na+ levels were determined by
Flame Photometer (Evans Electroselenium Ltd.) with
appropriate dilution. Since plasma contained a high
concentration of Na+, appropriate amount of NaCl was
added to the potassium ion standard solution. Mg++ and
Ca++ concentration were measured by atomic absorption
(Shandon Southern A 300) with appropriate dilution.
Lanthanum chloride (finial concentration 0.5$) was
added to the sample for Ca and Mg mesaurements.
(viii) Plasma Cl~
Plasma CI level was determined by a modification
of the method of Tietz (1973) 25 il of plasma was
mixed with 1 ml distilled water, 25 p.1 0.72N HSO and
25 yal 10$ sodium tungstate. After centrifugation,
100 p.1 of clear supernatant was added to 0.1ml
diphenylcarbarbazone and titrated with 0.01 N mercuric
nitrate (faint blue-violet color at end point).
(g) Liver Composition Analysis
Liver was homogenised in distilled water by glass
homogenizer with 20 folds dilution. The sample was stored
in freezer for later analysis.
(i) Liver glycogen
The liver glycogen content was determined by
method of Murat and Serfaty (197)• The liver glycogen
was hydrolized by amyloglucosidase to glucose. Then
glucose was estimated by coupled glucose oxidase-
peroxidase reaction (Sigma Technical Bulletin Nof510)
(see also plasma glucose determination p. 13)•
The liver glycogen content was expressed in mg of
glucose g of wet tissue.
(ii) Liver soluble protein
An appropriate volume (50-100 ;il) of liver
homogenate as previous prepared was taken out for
determination of liver soluble protein. The
homogenate was centrifuged and then the protein
content of supernatant was estimated by the modified
Lowry method (Hartree, 1972) as described previously
in plasma protein determination
(iii) Liver enzymes activities
a Glucose-6-phosphate dehydrogenase (G6PDH)






Liver homogenates diluted 20 fold were centrifuged
at 5OOOgfor 5 min. A series of reagents was prepared
Tris buffer 50 mM {6 mgml) (6 mgml)
EDTA 5 mM (2 mgml)pH was adjusted
to 76 with 5N NaOH
Glucose-6-phosphate: 30 mM (8463 ragml)
(Monosodium salt)
NADP 1 0 mK( 8 mgml)
The reagent was pre-incubated at 20°C for about
10 min A standard 1 cm curette was used. 2 ml buffer,
0.1 ml NADP and 0.1 ml of supernatant were added into
the curette. After thoroughly mixing the reaction was
started by adding 50 jx 1 of G-6-P. The curette was
pushed immediately into the spectrophotometer
(Spectronic 70). The increase in optical density at
366 nm over a period of 10 min was noted. Throughout
the test, temperature was kept at 200«5°C Enzyme
activity was calculated using the following relationship
and was expressed as p. mole NADPH producedg of soluble
protein min.
mole
b. Glucose-6-phosphatase (G6 Pase, E.C.3«1«39)
The activity of G6 Pase of the liver homogenate
(20 fold) was assayed by a modification of the method of
Harper (193)• The reagents used were as following:
Cacodylate buffer (01 M, pH 6.5)
2.11 g sodium cacodylate'3H0 dissolved in 50 ml
distilled water and pH was adjusted to 6.5 with 5N HC1,
the buffer was diluted to 100 ml with distilled water
Glucose-6-phosphate (Q.08 M)
This reagent should be freshly prepared,,
The G-6-Pase assay temperature was maintained
at 20°C. 0.1 ml of the cacodylate buffer and 0.1 ml of
0.08M glucose-6-phosphate were mixed together in test
tube. The reaction was started by adding 0.1 ml liver
homogenate and allowed to proceed for 30 min. The
reaction was terminated by the addition of 2 ml 10$
trichloroacetic acid0
Since G6Pase catalyze the following reaction:
Glucose-6-phosphate+ HO G6Pase giucose+ inorganic
phosphate
The activity of this enzyme was determined by the
amount of inorganic phosphate formation Inorganic
phosphate was assayed by the procedure of Fiske and
Subbarow (19 25)o
Tissue controls as well as reagent controls for
G6Pase assay was also carried out The enzyme activity
was expressed as p. mole phosphate released mg soluble
protein mm
00 Tissue water
Pieces of muscle (l-2g) and gill filaments (02-05g)
were put in preweighted tubes and weighed After drying
in oven at 80o-100°C for 48 hours, the samples were
cooled in desiccator Then, the samples were reweighed
and the percentage of tissue water was calculated by
weight difference
(i) Statistical analysis
All data were expressed as means+ standard error
of the mean (M iS,E M.) Student1 s t test was performed
to assessthe differences between groups.
2 Results
(A) Plasma hematocrit and osmolality
Intraperitoneal injection of arachidonic acid
(075 mgkg) significantly decreased plasma osmolality
(Fig 17) 2 and 3 hours after injection in snakehead,
PGF1(), also lowered plasma osmolality 3 hours after
intraperitoneal injection whereas no effect was observed
after PGA, PGB and PGE injection when compared with
their corresponding controls (Fig, 17)
Plasma hematocrit value was lowered 1 hour after
intraperitoneal injection of PGE (Fig, 18) However,
intravenous injection of PGE could not alter plasma
hematocrit value. Intraperitoneal injection of PGFC(.
significantly increased hematocrit value from 4o,6$ to
45$ (Fig. 18).
Moreover, PGE and aspirin treatment did not
produce any effect on hematocrit values (Fig, 19-)•
Although PGE.J injection did not affect the plasma
osmolality, aspirin and aspiri.n+ PGE treatment significantly
fell plasma osmolality in this fish.
(.b) Carbohydrate metabolism
Intact Fish+ Intraperitoneal Injection of PGs
Intraperitoneal ethanol injection increased plasma
glucose level in snakeheads. However, only the increase
in plasma glucose level at 2 hours after injection was
Fig. 17Effect of intraperitoneal injection of PGs, arach-
idonic acid (AA) and ethanol (ET) in plasma
osmolality of 6 snakeheads. Data were presented
in the Mean and SEM. AsPGAj, BsPGB1, EsPGE and
FsPGF... p002 and P 0001 when comparedA
with controls
Fig 18 Effect of intraperitoneal injection of PGs, arach-
donic acid (AA) and ethanol (ET) in hematocrit of
six snakeheads A=PGA f B=PGB, E=PGE and FsPGF
Results were presented in the Mean and SEM.

























































Fig. 19 Changes in plasma parameters, liver glycogen,
and muscle water in intact and aspirin treated
fish (6) after injection of saline and PGE.
S= saline, AS=salin© injected into aspirin
treated fish and A+PGE=PGE injected into
aspirin treated fish Data were expressed in
the Mean and vertical bar denotes SEM P
0.05, 0.02, P 0.01 and P 0.001
when compared with controls.
statistically significant when compared with zero time
controls (Fig 20) Arachidonic acid and PGA„ increased
plasma glucose 30 min after injection and PGB
significantly increased plasma glucose 1 and 2 hours
after injection0 Whereas PGE induced hyperglycemia
1 hours after injection, the hyperglycemia elicited by
PGF only occurred 3 hours after injection (Fig 20)
When the fish were injected with arachidonic
acid, the liver glycogen content were depleted 1,2 and
3 hours after injection (Fig. 21) Other PGs such as
PGA.J, PGB, PGE and PGF also decreased glycogen level
1 hour after injection, however these decreases were
not statistically significant Also, PGE injection
slightly decreased glycogen content in normal and
aspirin-treated fish. However, these decreases were
not significant (Fig 19)•
Liver Glucose-6-phosphatase (G6Pase) activity
varied greatly among the controls (Fig. 22). At 05
hour after injection, PGF, significantly increased
liver G6Pase activity in snakeheads whereas PGB
intraperitoneal injection significantly decreased this
enzyme activity Moreover, no effect on liver G6Pase
activity was observed with PGA, PGE and arachidonic
acid injections.
As well as G6Pase activity, liver Glucose-6-phosphate
Fig.20 Effect of intraperitoneal injection of ethanol
(ET), arachidonic acid (AA)f PGA.f (a), PGB1 (b),
PGE (E) and PGF (F) in plasma glucose of six
snakeheads, Vertical bar denotes SEM® X Pp®05
when compared with controls®
Fig. 21 Changes in liver glycogen content of six snakeheads
after intraperitoneal injection of ethanol (ET),
arachidonic acid (AA), PGAt (a) PGB1 (b), PGE1 (e)
and PGF (F). Vertical bar denotes SEM, P005
and P002 when compared with ethanol controls
Fig. 22 Changes in liver glucose-6-phosphatase (G6Pase)
activity of six snakeheads after injection of
ethanol (ET), arachidonic acid (AA.), PGA- (a),
PGB (B), PGE1 (E) and PGF1 (F). Vortical bar
denotes SEM. P0.05 when compared with controls.
dehydrogenase (G6PDH) activity also varied among the control
fish (Fig. 23). No effect on this enzyme was observed after
the injection of prostaglandins except PGF significantly
increased liver G6PDH activity 2 hours after injection.
Aspirin-treated Fish+ Intraperitoneal Injection of PGE
Plasma glucose level was greatly elevated by PGE
(0.75 mgkg) intraperitoneal injection in snakeheads
with or without aspirin treatment (Fig. 19)«
Cannulated Fish+ Intravenous Injection of PGE
Intravenous injection of PGE (30p.gkg) significantly
increased plasma glucose concentration 30 and 60 min after
injection whereas injection of ethanol saline (ls4 by vol.)
did not alter plasma glucose level in snakehead (Fig. 24).
(c) Lipid metabolism
1 and 2 hours after intraperitoneal injection of
PGE, a significant decrease in plasma lipid level was
observed (Fig. 25). This result was repeatabl© in a separate
experiment involving intravenous injection of PGE into the
gonadal vein via an indwelling cannula. However, there were
no change in plasma lipid concentration after injection of
PGA.J, PGB1, PGF and arachidonic acid in snakeheads. Also
ethanol injection did not change plasma lipid level.
In aspirin treated fish, a decrease in plasma
Fig. 23 Effect of intraperitoneal injection of ethanol (ET)
„arachidonic acid (AA), PGA (a), PGB1 (b), PGE1 (e)
and PGF (F) in the liver glucose-6-phosphate
dehydrogenase (G6PDH) activity of six snakeheads.
Data were expressed in the Mean and SEM. P00.2
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Pig. 24
Effect of intravenous injection of PGE1
(30 igkg) in plasma glucose of five
snakeheads Data were presented in
Mean+ SEM, P005 and P002
when compared with controls
Fig. 25 Changes in plasma lipid level of six snakeheads
after injection of ethanol (ET), arachidonic acid
(AA), PGA1 (A), PGB1 (B), PGE (E) and PGF1, (p).
Data were expressed in the Mean and SEM. P0.05
and P0,02 when compared with controls.
lipid level was also observed (Fig 2 6) However,
injection of PGE in the aspirin treated fish could not
produce observable decrease in plasma lipid level when
compared with aspirin treated controls
Also plasma free fatty acid level was lowered 2 hours
after PGE injection while other PGs and arachidonic acid
did not alter plasma free fatty acid concentration in
snakeheads (Fig. 27)
( d) Plasma protein
Intraperitoneal injection of PGE lowered plasma
protein level 1 and 2 hours after injection (Fig. 28)
1 hour after intravenous injection of PGE also decrease
plasma protein level significantly (Fig 29)• also
decrease plasma protein level 2 and 3 hours after
intraperitoneal injection However, PGA, PGB and
arachidonic acid and ethanol could not alter plasma protein
at any time interval (Fig. 28)
Plasma albumin level significantly fell in snakeheads
3 hours after PGF1 intraperitoneal injection (Fig 30)
3 hours after intraperitoneal injection of PGE and PGB
there was a drop in plasma albumin concentration. A fall
in plasma albumin level was also observed in snakeheads
05 and 2 hours after PGA injection and arachidonic acid
also decreased albumin level 1 hour after injection
Fig. 26 Effect of intraperitoneal injection
of PGBj in gill watef and plasma-, lipid
level of intact and aspirin treated
fish S=saline, E=PGE, AS=ssaline
injected into aspirin treated fish,
A+E=sPGE injected into aspirin treated
fish Data (6 observation) were expressed
in the Mean and SEM. P002, 0.01
P 0001 when compared with controls
Fig 27 Changes in plasma free fatty acid level after
intraperitoneal injection of ethanol (ET)
arachidonic acid (AA), PGA (a), PGB (B),
PGE (E) and PGF (F).in six snakeheads
Data were expressed in the Mean and SEM
P4 0.02 when compared with controls.
Fig 28 Changes in plasma protein level of six snake-
heads after injection of ethanol (ET), arach-
donic acid (AA), PGA (a), (B), PGE1 (E)
and PGF (F) Data were expressed in the
Mean and SEM P 002 and P 0«01
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Fig 29 Effect of intravenous injection of PGE
in plasma protein level Data were expressed













Fig. 30 Changes in plasma albumin level of six snakeheads
after injection of ethanol (ET)f arachidonic acid
(AA), PGAt (A), PGBt (B), PGE1 (e) and PGP, (P).
Data were presented in the Mean and SBM.
P 0.05» P 0.02 and P 0.01 when
compared with corresponding controls.
A drop in plasma globulin was observed 3 hours
after PGF injection while there was no effect of
arachidonic acid and other PGs injection (Fig. 31).
In aspirin experiment, a decrease in plasma
protein was found in PGE injected intact and aspirin
treated fish (Fig. 19, p..)•
(0) Plasma electrolytes
A decline in plasma Na+ was observed in snakeheads
1 hour after intraperitoneal injection of PGF. 2 hours
after arachidonic acid injection, plasma Na+ level was
lowered whereas PGA, PGE and PGB could not modify this
electrolyte level in snakeheads (Fig. 32). However,
aspirin treatment elicited a drop in plasma Na+
concentration and PGE injection in normal and aspirin
treated fish did not alter plasma Na level (Fig. 19,
P. 1kk)•
PGF„ 1 decreased plasma K level 0.5 and 3 hours
after intraperitoneal injection and PGE also produced a
decrease in K+ level 1 hour after injection (Fig. 33)
Aspirin treatment exhibited no effect on plasma K+ in
snakeheads. 2 hours after injection of PGE in normal
and aspirin treated fish, plasma K+ level was unchanged.
Plasma Cl was slightly but not significantly elevated
by PGE and aspirin treatment abolished this increase.
Moreover, Mg and Ca levels were not altered by aspirin
Pig. 3T Changes in plasma globulin level of six
snakehoads after injection of ethanol
(ET), arachidonic aoid (AA), PGA (A)
PGB1 (B), PGEt (E) and ?GPl0 (F).
Data were presented in the Mean and
SEM when compared with
controls.
Fig. 32 Changes in plasma Na+ level after injection
of ethanol (ET), arachidonic acid (AA),
PGAt (A), PGB1 (B), PGE1 (e) and PGF1(X (F)
in six snakeheads. Data were expressed in
the Mean and SEMe P 002 and X
P 0.01 when compared with controls
Eig« 33 Changes in plasma K level after injection
of ethanol (ET), arachidonic acid (AA), PGAj
(A), PGB1 (B), PGE1 (E), PGP (p) in si
snakeheads« Data were expressed in th© Mean
and SEM. xx P4002 and xss P:O0O1 when
compared with controls.
treatment, PGE injection in aspirin treated fish and
single PGE injection (Fig. 19, p. i44)•
( f) Tissue water
Gill water content was elevated by intraperitoneal
injection of PGE in normal and aspirin treated fish
(Pig. 26). However, aspirin treatment produced no effect
on gill water content.
There was no change in muscle water content after
injection of PGE in normal and aspirin treated fish.
Also aspirin treatment could not induce change in muscle




In the present experiments, intraperitoneal
injection of ethanol (1.5 ml/kg) significantly increased
plasma glucose level in snakehead 2 hours after
admirnstration (Fig. 20, pp. 14). Hollstedt et al.
(1980) reported that intraperitoneal injection of ethanol
in rat also increased plasma glucose level and the blood
ethanol concentration fell to zero before 180 minutes.
Moreover, chronic ethanol (5 weeks liquid diet)
consumption resulted in increase of oxidation of
arachidonic acid to prostaglandin and suppression of
prostaglandin E and F catabolism (PGE2 to 15-keto-PGE2
in lung) (Pennington et., 1978). However., in the
present experiments, only one low dose of ethanol was
injected into the snakeheads. It is presumably that
this single dose of ethanol may not result in increased
PGs synthesis snakeheads.
Although intraperitoneal injection of ethanol
increased plasma glucose in snakeheads, Prostaglandins
also produced hyperglycemia when compared with their
corresponding ethanol controls. The hyperglycemic effect
of Prostaglandins in snakeheads is consistent and
repeatable. In the aspirin experiments, PGE1 (suspended
in 0.9% NaCl) were injected in the normal and aspirin
treated snakeheads, a marked increase in plasma glucose
was observed. This increase is about 200 of the basal
glucose level. Moreover, intravenous injection of FGE
also significantly increased plasma glucose 30 and 60
min after administration. PGA, PGB. and PGF., also
produced increase in glucose level in snakehead eventhough
the PG precursor, arachidonic acid increased plasma
glucose concentration. This suggests that these k types
of prostaglandin can produce hyperglycemic effects in
shakeheads.
The hyperglycemic effects of PGE, PGA in mammals
and birds have been published (Sanbar et al, 197 5
Lemberg et aJ.., 1 971 5 Sacca ejfc ajL., 1 973 5 Berti ejt auL.,
1965; Grande and Prigge, 197). The present results of
PGE-and PGA-induced increase in plasma glucose in
snakehead is in accordance with those reports on mammals
and birds.
However, there are very few reports of PGB, PGF
and arachidonic acid effects on carbohydrate metabolism
(Pento et al., 197°). The present investigation demonstrated
that PGB., PGF..and arachidonic acid all exhibited
hyperglycemic effect in snakehead although their effects
occurred at different time interval after injection.
PGA.J and araahidonic acid induced hyperglycemia 0.5 hour
after injection. PGB increased plasma glucose 1 and 2
hours after injection. 1 hour after PGE injection and
3 hours after injection of PGF induced a rise in plasma
glucose.
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The blood glucose level at any given time is
determined by the balance between the amount of glucose
entering the blood stream and the amount leaving it.
The principal determinants are therefore the dietary
intake, the rate of entry into the cells of muscle, adipose
tissue and. other organ, and the glucostatic activity of the
liver (Gangong, 1977) In the present studies, the
snakeheads were unfed for at least 2 weeks before
experimentation, therefore, the increase in plasma glucose
would not come from the dietary intake, PGE1,has been
shown to produce a sharp increase in the %-of glucose
transformed to fatty acid in adipose tissue (Crawford
and Haessler, 1968 Rettberg, 1968). Hence this may
eliminate the possibility that the rise in blood glucose
is due to a decline in the rate of glucose into tissues.
Therefore the increase in plasma glucose is most likely
due to the alteration of glucostatic activity of the liver.
There are two possible ways of formation of glucose:
gluconeogensis and glycogenolysis. Since liver contains
a large amount of glycogen, an analysis of liver glycogen
a
content will provide information of glycogenolytic
activity. Intraperitoneal injection of arachidonic acid
significantly depleted liver glycogen content 1, 2 and 3
hours after injection. PGA1, PGB1, PGE1 and PGF1, also
slightly decreased liver glycogen level 1 and 2 hours
after intraperitoneal injection. Hence, the source of
plasma glucose seems to be the result of glyco genolysis.
167
However, a very slight but not significant decrease in
liver glycogen occurred in PGE1 injected normal or
aspirin-treated fish. These results suggest that PGs
may directly or indirectly affect the glycogendlytic
activity in liver and promote glycogenolysis and result
in increased plasma glucose level in snakeheads.
May et al. (1969) published that intraperitoneal administration
of PGE1 to rat decreased glycogen content of the liver
and induced hyperglycemia in mice. The present results
in snakehead agrees with those results from mammals.'
Moreover, the hydrolysis of G6P is a key reaction
both in gluconeogene sis%__and' in `the conversion of liver
glycogen to blood glucose and glue ose-6-phosphatasop(G6Pase
catalyses this reacfion(Hochachka, 1969). PGF1 Significantly
increased liver G6Pase activity I hour after injection
whereas PGB1 decreased G6Pase activity, 2 hours after
administration. However, PGA1, PGE1 and arachidonic acid
did not-alter this enzyme activity. From the previous
suggestion of PGs promoting glycogenolysis, an-increase
in G6Pase activity is expected. This anomalous findings
cannot be explained in present experiment.
Moreover, it has been reported that in mammals,
PGE1 caused a significant decrease in glycogeiz synthetase
activity regardless of nutritional status or presence or
absence of adrenal glands (Curnow and Nuttall, 1972).
In the present study on the snakehead, PGE1 also increased
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liver phosphophosphorylase activity. These changes in
enzyme activities are compatible with the proposed
increase in hepatic cAMP and suggested possible direct
effects on hepatic glycogen level. On the other hand.
Exton et al. (1971) and Levine (1974 19'/9)- showed' that
PGE1 and PGF2 perfusion in rat liver failed to alter
cAMP levels or glucose production.
In Part II (pp. 117), a low 02 consumption rate
was observed 10-15 min after intravenous injection of
PGE1 and it was suggested that this decrease is due to
the alteration of. metabolism, in snakeheads. However,
Willebrands and Tasseron (1968) reported that PGE1 and
PGF1a increased glucose oxidation in isolated rat heart.,
Moreover, PGE1 and PGF1 promoted oxidation of glucose
to CO2 in epididymal sperms. However, PGFq reduced 02
consumption while PGE1 had no effect in epididymal sperms.
Besides the oxidation of glucose via glycolysis and
.Kreb's cycle, the other pathway is pentose phosphate
pathway and glucose-6-phosphate dehydrogenase (G6PDH) is
the key enzyme of this metabolic pathway.' Only PGF1,
increased G6PDH activity 2 hours after injection whereas,
PGA1, PGB1 and PGE1 did not affect this enzyme activity'
The exact importance of this finding is obscure. However,
it must be pointed cut that PGE1 promoted glyceride-fatty
acid formation from glucose in adipose tissue
(Vaughan, 1966), In the present result, enhanced pentose
phosphate pathway activity due to PGF injection may
contribute to tbe promotion of fatty acid, formation
from glucose
Although the present results cannot provide the
general conclusion on the mechanisms of PGs actions in
carbohydrate metabolism, PGs induced hyperglycemia is
consistent In addition, the subsequent experiments
have been designed to examine the possible direct actions
of PGs on liver glycogen metabolism
(b) Lipid metabolism
In vivo effects of PGs on plasma lipid are dependent
upon the dose of PGs and the kind of experimental mammals
PGA infusion in anaesthetized dog produced an increase in
plasma FFA level (Sacca et ad, 1973) and PGE injection
also elevated the plasma FFA and glycerol level in man
(Bergstrtfm ejfc al•, 1965) and in goose (Grande and Prigge,
1972)o However, Sanbar et; al (1967) reported a con¬
tradictory result and plasma FFA level was lowered by
injection of PGE From the present results, the PGE
effect on plasma free fatty acid and lipid in snakeheads
was in conformity with the results of Sanbar ejb ad (1967)
PGE.J injection significantly decreased plasma free fatty
acid and lipid level in the fish However, these levels
were not affected by other PGs, such as FGA, PGB,
PGF .j and arachidonic acid in snakeheads From the results
studied on humans, PGA and PGE infusion induced plasma
FFA but F series of PG produced no significant change in
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plasma FFA level (Carlson et al., 1970a),
In the other set of experiments done on snakeheads,
a PGE1-induced drop in plasma lipid was observed. On
the other hand aspirin also lowered plasma lipid level
in snakeheads. However, PGE1 injection in aspirin
treated fish did not decrease plasma lipid. The results
are quite controversial and cannot be explained in the
present investigation.
Moreover, PGE1 produced a dose-dependent effect
in plasma FFA level of anaesthetized dog (Bergstrom
et 1., 1966)e A low dose of PGE1 incteased FFA level
while high doses decreased plasma FFA. Bergstrom et 1#
as well as Somova and Dochev (1970) suggested that low
dose of PGE1 stimulated the sympathetic nervous activity
(enhanced lipid mobilization) while high dose of PGE1
has a direct inhibit effect on 11'FA mobilization from
adipose tissue.
Due to the dose- and mammal-dependent response to
PGE1, however, intraperitoneal injection of PGE1
0.75 mg/kg) produced a fall in plasma lipid and free
fatty acid in snakehead. In the succeeding experiments,
an investigation of PGs actions on lipolysis in adipose
tissue has- been carried out.
( c) Protein metabolism
Most of the work on PGs and protein synthesis
is related to collagen. In other experiments, local
application of PGE and PG seems stimulate
incorporation of labeled amino acids into collagen whereas
PGF inhibited this incorporation (Lupulescu, 1975)
(for details, see Horrobin, 1978) However, the present
studies seem to be far away from studies of PGs effects
in collagen synthesis. Therefore, it is hard to relate
the present results of PGs effects or plasma protein
level in snakeheads in relation to collagen synthesis.
The present findings showed that 1 and 2 hours
after PGE intraperitoneal injection produced a significant
drop in plasma total protein levels. PGF also induced
the same effect in snakehead 2 and 3 hours after injection.
Regardless of the presence or absence of aspirin treatment,
intraperitoneal injection of PGE also lowered plasma
protein. The same response occurred when the snakeheads
received intravenous PGE administration. From the
above results, PGE-and PGF-induced decrease in plasma
protein in snakehead is reliable. However, PGA, PGB
and arachidonic acid did not affect plasma total protein
level in snakehead.
Since the main components of plasma protein are
globulin and albumin, an examination of plasma globulin
and albumin may indicate the cause of PGs-induced decreased
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plasma protein.
Only PGF1 was shown to lower plasma globulin
level 3 hours after injection whereas no effects of
other PGs were observed. Moreover, PGA1, PGB1, PGE1,
PGF1,,,and arachidonic acid all could lower plasma albumin
level in snakeheads although their effective time intervals
were different. These results seem not to agree with
the results on plasma protein (only PGE1 and PGF1a decreased
plasma total protein). It has been well known that plasma
protein is synthesized and released from the liver
(Putman, 1975). Working on the killifish, Horseman and
Meier (1979) demonstrated that prolactin stimulation of
hepatic RNA synthesis was blocked by indomethacin.
Furthermore, they showed that PGF2d(stimulated hepatic
RNA synthesis. Thus, these results seem to be in contrast
to our present findings.
Of course, the present examination cannot give any
mechanism of PGs actions on protein metabolism in
snakehead. Moreover, this now finding requires further
investigation.
(.d) Water and ion levels of plasma and tissues
PGFsignificantly lowered plasma Na+ and K+ levels
0.5 hour after injection whereas no effect was observed
in plasma osmolality and hematocrit value. This shows
that PGF1 -induced decrease in Na+ and K+ levels is not
due to hemodilution Moreover, 3 hours after PGF1
administration, decreased plasma osmolality and K level
were observed but there was no observable change in
hematocrit and plasma Na Although PGF could not
produce consistent results, it is certain that PGF has
an osmoregulatory role in snakeheads. Of course, it
cannot be explained at the present time
Furthermore, PGE declined hematocrit value and
plasma K level 1 hour after intraperitoneal injection
while plasma Na+ and osmolality remained unchanged
In the other set of experiment, a remarkable drop in
+
Plasma Na level was found in aspirin treated fish. In
the same experiment, PGE injection could bring plasma Na+
back to normal level in the aspirin treated fish Plasma
Cl~ inclined to increase but it was not statistically
significant. Aspirin treatment seemed to abolish this
PGB -induced increase in plasma Cl~. However, aspirin
1
treatment alone could not produce any effect on CI level.
From other reports, PGE and PGF were shown to inhibit
Na and Cl~ outflow in seawatter acclimated mullet (Pic,
1975). Ala o PGE.J injection elevated plasma Cl level in
killifish (Horseman $nd Meier, 1978)
Besides, aspirin treatment also reduced plasma
osmolality but PGE could not modify this effect. Further,
i
either PGE injection or aspirin treatment did not alter
4 4 4 4
plasma Mg, Ca levels and hematocrit value in snakeheads.
In addition, arachidonic acid decreased plasma
osmolality 2 and 3 hours after injection and induoed
a drop in plasma Na+. The other PGs, such as PGA and
PGB did not change plasma Na+, CI, osmolality and
hematocrit in this fish.
Besides estimating plasma ionic levels, muscle
i
and gill water content of the aspirin-treated fish were
also measured. PGE declined gill water content of
intact and aspirin-treated fish while muscle water
content was elevated only in aspirin-treated fish. Other
f
report Remonstrated that an increase in synthesis
of incubated gill from a marine bivalve was induced by
hyposmotic stress (Freas and Grollman, 1980). Further,
PGE reduced Na influx in fresh water mussel (Graves and
Dietz, 1979) jLE vitro studies, PGE reduced vaso-
Y
pressin and theophylline-induced osmotic flow across the
toad urinary bladder and PGE also increased short-
circuit current in this preparation (Urakabe, 1975)«0
All these results show that PGs are involved in
osmoregulation in these animals.
The present experiments show that exogenous PGE
and PGF do play a role in the regulation of plasma
osmolality, ionic levels and tissue water content. At
the same time, endogenous PGs are also shown to be involved
in maintaining ionic levels in the snakeheads and this
is in accordance with the report of ¥00 et; al (1980).
The present studies cannot reveal the rnechansion of
PGs actions in osmoregulation of this fish and further
investigations are required©
(3') In vitro studies
1 Materials and Methods
(h) Removal of liver and fat tissue
Snakeheads were kept as previously described
(pp. 83). The animals were sacrificed by cutting
through the cervical vertebral column® Then the abdomen
was cut open and the whole liver was amputated immediately8
Fatty tissue distributed around the peripheral region
of intestine was also removed® The isolation of liver
and fat cells were undertaken immediately after removal®
( b) Liver cells preparation and incubation
This preparation followed the modified method
of Seglen (1964).
(i)Preparation of liver cells


























































Salt concentrations were given in milligrams per 1000 ml
of final solution, and the concentration of NaOH (1M)
as milliliters per 1000 ml of final solution. The two
strongly buffered solution (collagenase buffer and
suspension buffer) were designed to withstand continous
acidification by the liver cells, and therefore had a
high initial pH. All buffer solutions were prepared with
well aerated distilJ.ed water.
1 b 0After removal from the fish, the liver was immediately
placed in a petri dish containing 20 ml of Ca++-free
perfusion buffer. The hepatic vein was catheterized with
f
a polyethylene tube (PE-6o). This cannula was connected
with another polyethylene tube (diameter about 0,3 cm).
The perfusion buffer was aerated and pumped by a varistatic
pump into the liver via the polyethylene tube at a rate
of 0.05 mlsec. Then the perfusate was allowed to leak
freely from the hepatic portal vein and hepatic artery.
The liver was continously perfused with recirculating
buffer for 20 min.
+•(-
c After 20 min perfusion, the Ga -free perfusion
buffer was replaced by collagenase buffer (15 ml).
Then the perfusion was continued for 1 hour and the buffer
was aerated throughout the perfusion.
d After all of the above treatments, the liver became
swollen to more than twice its original size. The liver
was then transferred to a small petri dish containing
10 ml washing buffer. While the liver was held in the
portal region with forceps and gently shaken, the cells
were liberated from the connective vascular tissue by
careful raking with another pair of forceps
e The cell suspension was filtered through a coarse
nylon filter to remove connective tissue debris and
clumps of infarctious tissue The cell suspension was
centrifuged and the washing buffer was pipetted out
Then the content was rewashed again Then the washing
buffer was discarded and replaced by approiate amount
of suspension buffer The liver cell suspension was
subjected to experimentation
(ii) Incubation of liver cell suspension
The liver cell suspension (containing 10-15 nig of
liver wet weight) was incubated with PGA, PGB, PGE
and PGF.J (dose 25 jugml) (all PGs were initially prepared
in 0»5 mgml ethanol). Ethanol (50 yal) was added into
the cell suspension as control In another set of experiment,
insulin (h unitml) and epinephrine (50 igml) was added
into the cell suspension and an appropriate amount of
09$ NaCl was added in the cell suspension as control
The cell suspensions- were incubated at 20°C and were
continously shaken At zero, 1, 2 and 3 hours after
incubation, 100 il of cell suspension was taken out Then
the content was centrifuged and supernatant was transferred
into another tube Then the glucose content of the
suernatant was estimated by glucose oxidase-peroxidase
method (see p. 13). The precipitate was saved and the
excess supernatant was poured out. Then the precipitate
was weighed and 200 p. 1 distilled water was used to break
down the liver cells. Then the content was frozen for later
analysis of enzymatic activities.
Another 100 pl of cell suspension was also taken out
at zero, 1, 2 and 3 hours after incubation. Then the cell
suspension was centrifuged and the supernatant was discarded.
The precipitate was saved for glycogen measurement (see
P 137).
(iii) Enzymatic activities of liver cells
The soluble protein content of liver cells was estimated
(see p. 134). G6Pase, GOT and GPT activities of liver
cells were also determined. The measurement of G6Pase
activitiy was same as previously described( p. 139)..
Activities of the enzymes, glutamate oxaloacetate
transaminase (GOT; L-aspartate: 2-oxoglutarate aminotrans¬
ferase; E.C.2,6.1.1) and glutamate pyruvate transaminase,
in the liver were assayed by the method described in Sigma
Technical Bulletin No. 505-Transaminase (GOT and GPT)• A
micromodification was employed in which 0.5 nil substrate,
0.05 ml liver homogenate (20 fold dilution), 0.5 ml color
reagent and 5 ml 0.4N NaOH solution were used. The assay was
carried out at 20°C in a water bath. The enzymatic activities
were expressed as S-F units rng protein (one theoretical
Sigma-Franke 1 (S-F) unit of GOT or GPT will form .82 X 10
-1
iM of glutamate min at pH 7.5 and 25°C).
( c) Liver slice preparation and incubation
Liver was removed from fish and then was immediately
frozen. A cooled slicer (Stadie-Riggs) was used for
slicing the liver. The liver slices were about 0,5-1 mm thick.
About 100 mg of liver slice was weighed and then was suspended
in 1 ml suspension medium (the same suspension medium as in
liver cell incubation), 25 71 g of dry PGA, PGB, PGE, PGFy
arachidonic acid and 25, 50 yug of epinephrine were added into
the suspension medium. The content was incubated at 20°C water
bath and was continously shaken for 2 hours. After incubation,
the liver slice solution was centrifuge and the precipitate
was homogenized using an Ultra-Turrax homogenizer. The homo-
genate was stored in freezer for later GOT, GPT and glycogen
phosphorylase A activities estimation.
GPT and GOT activities measurement were understaken as
previous described (pp. 179 )o Glycogen phosphorylase A
activity was determined by method of Bergraeyer( 1970®
3-
Glycogen phosphorylase A activity was expressed in P0 mM•
g protein 0 hr'«
(d) Fat cell preparation and incubation
A modification method of Rodbell (1964) was
employed to prepare the fat cells All containers
used in fat cell preparation and incubation were made of
plastic
(±) Composition of Krebs Ringer+ Collagenase
















19 ml NaHCCk (13$) was added in 100 ml of above
mixture 2 g albumin (Sigma) and 108 mg glucose (Sigma)
were added into the second mixture. Then 10 jig collagenase
per ml of final Ringer solution was prepared.
Isolation of fat cells
The fat tissue (2 g) removed from the fish was
immediately transferred into a plastic beaker with
3 ml of Kreb1s Ringer+ Collagenase solution. The fat
tissue was cut into small pieces and was digested for
1 or 1,5 hour at room temperature Then the cell
suspension was filtered through a nylon filter. The
filtrate containing free fat cells was washed with
Ringer solution and then was centrifuged. After low
speed centrifugation, the fat cells floated on the top
and the lower fraction was discarded The cell suspension
was rewashed again and the cell suspension was prepared
for incubation.
(iii) Incubation of fat cells
PGA, PGB, PGE and PGF were gifts from
Upjohn Company. These PGs were dissolved in 0.5 mgml
ethanol. Appropriate amount of PGs (20 ig15 nil) was
added into fat cell suspension (0,1-0.2 g of fat weigh).
20 il of ethanol was added in the cell suspension and
was used as control.
The cell suspension was incubated at 20 C and was
continuously shaken. At zero, 12, 3fh and 5 hours,
200 jal cell suspension was taken out(before taking out
the cell suspension, full mixing of fat cells and
suspension medium was ensured). The samples were
immediately frozen and saved for glycerol determination.
(iv) Glycerol determination
Glycerol content was determined by enzymatic
method (glycerol dehydrogenase, Sigma). The formation
of NADH after the enzymatic reaction was detected. The
reagents were prepared as follow:
0.1 M Ammonium Sulfate
?-NAD Solution( 7 mg l-NAD (Sigma), grade III,
per ml HO, adjust pH to 70-
75 with solid NaHCO)
0.5 M. Carbonate Buffer pH 10.0
1.0 M Glycerol (For standard)
5 unitml Glycerol Dehydrogenase Solution
(0.05 potassium phosphate pH 75)
To a cuvet of 1 cm lightpath, 0.05 ml Ammonium
sulfate, 0.05 ml -NAD solution, 0.3 nil carbonate buffer
and 0.7 nil distilled water were added. Then 200 pi sample
and 20 p 1 glycerol dehydrogenase were mixed with the
above solution. Then the mixture was allowed to incubate
at room temperature for 3 hours and then was read at
30 nm.
( e) Statistical analysis
All data were expressed as Mean- Standard Error
of the Mean. Statistical analysis was determined by
Student's t test'
(a) Liver cells
A gradual release of glucose from incubated
liver cells was observed (Fig. 35). However, PGA, PGF
PGB.J, PGE, ethanol could not produce any change in
the rate of glucose release from liver cells.
Although epinephrine declined glucose release, a
statistical significance was only observed at 120 min
after incubation.
In the case of liver cell glycogen, a moderate
decrease of glycogen content was shown (Fig. 36).
The glycogen content was significantly higher in PGE
and PGF.J treated group when covnpared with their
corresponding controls (ethanol group) 2 hours after
incubation, A higher glycogen content was found in
insulin-treated liver cell 1 hour after incubation.
Other treatments such as epinephrine, PGA and PGB did
not alter the glycogen content of liver cells at any
time interval.
Since glycogen level of liver cell was significantly
elevated 2 hours after PGE and PGF treatment, the
enzyme activities of liver cells at this interval were
measured. GOT and GPT activities were not altered by
PGE.J, PGIjand epinephrine when compared with their
corresponding controls (Fig. 37) Also no change was
found in G6Pase activity in alx these treatment
(Fig. 38).
Fig. 35Effect of PGs, ethanol (ETOH)f
epinephrine (EPl), insulin (INS),
saline (CON) in the glucose release
of isolated liver cells© Data were
expressed in the Mean and SEM©








1 hr 2 hr 3 hr
TIME AFTER INCUBATION
Fig. 36 Effect of PGs (A=PGA, B=PGB1, E=PGE1
F=PGF), ethanol (ET), epinephrine
(EP), and insulin (i) (Cscontrol) in
glycogen content of isolated liver cells.
Data were presented in the Mean and SEM.
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Fig 37Effect of epinephrine (EPl), ethanol (ETOH)
PGE, PGF (CONsscontrol) in glutamate oxal«
acetate transaminase (GOT) and glutamate
pyruvate transaminase (GPT) activities of
isolated liver cells at 2 hours after
incubation Data (six observation) were








Effect of PGE1 (PGE) f PGF(PGF),
b£inephrine (EPl) and ethanol
(ETOH) (CONs=saline control)
in glucose-6-phosphatase (G6Paso)
activity of isolated liver cells
at 2 hours after incubation Data
(6 observation) were expressed in












The GOT and GPT activities of liver slice in
controls were 1844.4 i 214 and 1058.8127 unitmg protein
respectively while glycogen phosphorylase A activity
was 92 i 92 P0 niMg proteinhr. No effect was
observed in GPT, GOT and glycogen phosphorylase A
activities in any treatment (Table 8).
V',
(c) Fat cell
A plot of rfo change in glycerol production over
buffer control after various PGs treatment was presented
in Fig. 39« A decrease in glycerol production caused
by ethanol was demonstrated. PGB remarkably promoted
glycerol production in the isolated fat cells. An
PGF -induced increase in glycerol production was also
shown but the elevation was not significant. Further,
PGE.J and PGA produced no effect on glycerol production.
• •
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Liver slice was incubated for 2 hours and then GOT, GPT and glycogen
phosphorylase A activities were determinedo
: 0.9NaCl(20 jilml) was added as control in the liver slice incubation
medium.
Fig. 39Effect of othanol (ETOH) and PGs in
glycerol production of isolated fat
cells Data (6 observation) were
expressed in the Moan and SEM» PGB
significantly increased glycerol
nrnrfnftt-i on( V£. O. 001 1
3 Discussion
A gradual decrease in glycogen content of liver
cells and a moderate increase in glucose level of
suspension medium indicated that a degradation of
glycogen into glucose and released out was proceeding
in the liver cells during incubation. The data showed
that PGs did not affect the rate of glucose release
from liver cells. Only epinephrine depressed glucose
release from liver cells. This result is in contrast
to the result reported on other fishes: epinephrine
produced hyperglycemia in the eel (Larsson, 1973;
¥00, 1976) and goldfish (Young ejt aT., 1965).
Moreover, a higher glycogen content was observed
in the liver cells treated with insulin. However, this
increase in glycogen did not accompany a decrease in
glucose release. Furthermore, insulin has been shown
to promote glycogen synthesis and glycogen is deposited
in the muscle of lamprey (Murat ej; al., 1981).
PGE.J and PGF also olevated liver glycogen content
in liver cells whereas PGA and PGB produced no effect.
This is also a suprise to find that PGE and PGF
induced increase glycogen content in liver cells since
many reports have been published that PGE infusion
induced a significant increment in the average glucose
levels in the perfusate of the isolated perfused rat
liver (Lemberg ert al•, 1971)» PGE also activated
glycogen synthetase activity and increased glycogen
phosphorylase A activity in rat liver (Curnow and
Nuttall, 1972). However, in present studies, liver
phosphorylase A activity in snakehead was not altered
by any PGs. Also G6Pase activity in the isolated liver
cell was not modified by PGE or PGF or epinephrine
treatment, Levine (1979) also found that PGE did not
promote hyperglycemia, glycogenolysis, lipolysis,
or prevent epinephrine-induced hyperglycemia in the
isolated perfused rat liver. Further, this author and
his coworker (Levine and Schwertzel, 1980) reported
that PGE alone could not depress glueoneogensis while
PGE inhibited glucagon induced gluconeogensis in rat
liver. Therefore, the inability of PGs in activation
of gluconeogensis or glycogenolysis in isolated
snakehead liver slice or liver cells indicates that
hyperglycemic effect of PGs may be mediated through
the action of other hormone(s) (e.g. glucagon).
In the previous results, PGE and PGF1 significantly
declined plasma protein level in snakeheads, Further
GPT and GOT are the enzymes involved in the transamination
from an amino acid to a keto acid, A change in activity
of these enzymes may show an alternation of amino acid
metabolism. However, PGA, PGB, PGE,
arachidcnic acid and epinephrine did not change these
two enzymatic activities in the liver slice.
In the present studies, only PGB was shown to
stimulate lipolysis in the isolated fat cells since
a marked increase in glycerol production was demonstrated
PGF also elicited 'a lipolytic effect on fat cell
although the effect was not statistically significant
Other PGs (PGA and PGE) did not exhibit action on
lipolysis in fat cells Ethanol could not exert a
significant effect on lipolysis in fat cell. This
result agreed with the report of Nilsson and Belfrage
(197S) on effects of ethanol on lipolysis in isolated
rat adipocytes
Since no report on PGB effect on lipolysis has
been published, the present result of PGB-induced
lipolysis in snakehead fat cells cannot be compared
with other report It has published that PGFy inhibited
epinephrine-induced lipolysis in mammal (Handler al,
1965) However, in the snakehead fat cells, PGF seems
to promote rather than inhibit lipolysis
The present data showed that PGE could not
inhibit lipolysis in vitro fat cells This result is
in contrast to the previous result of PGE in in vivo
studies In in vivo studies, PGE significantly lowere
plasma FFA and lipid level 2 hours after injection
This decrease in plasma FFA is presumbably due to the
antilipotic effect of PGE (for details, see also
Literature Review, pp. 53-58)• Many reports
have demonstrated that PGE has ant i'lipo lytic action
in both the in vitro and .in vivo experimental conditions
(see Literature Review, pp. 53-58)• One of the
possibility causing the disaccordance of the results
from in vitro and in vivo studies in snakeheads is that
PGE-induced lipolysis is mediated by other hormones
(such as insulin), therefore in in vitro studies, this
mediation is blocked and no lipolytic effect can be
observed. The other possible factor may be due to the
absence of GTP in the fat cell incubation medium.
Other reports showed that GTP is necessary on the action
of PGs and other -adrenergic agonists in reducing
hamster fat cell adenylate cyclase activity (Aktories,
et al.. 1979; Watanabe et al., 1979; Kather and Simon,
1979). However, the present investigation cannot
• provide support for these two possibilities.
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It has been well known that prostaglandins have a wide
spectrum of biological and pharmacological functions.
However, most of these studies were performed on mammalian
systems. Therefore, the present studies only focused on the
effects of PGs in a lower vertebrate-snakehead fish. Since
PGs possess versatile actions, only the studies of certain
effects of PGs were carried out in the present investigation.
The present results showed that PGs do exert cardiovascular,
metabolic and osmoregulatory actions in this fresh water
fish.
The doses of PGs employed in the fish were high and it
may be in pharmacological rather than physiological range.
However, a minimal dose of 2Ugkg of PGs was required to
produce cardiovascular response in snakeheads. Form the other
reports on mammals, a very low dose of PGE (0.02yhgkg)
could elicit these cardiovascular responses (Jones, 1972)
s
while 9ytigkg of was required to produce the same effect
in bullfrog (Leffler et aJL•, 19 80). Also the duration of
response to PGE are different among mammals, amphibians and
fish and a longer recovery time is found in lower vertebrates
(in human: 3 min (Karim e_t al., 1971) 5 in bullfrog; 10 min
(Leffler ejb al., 19 8o); in snakehead: 20 min). Moreover,
PGE intravenous injection produced a hyperglycemic effect
in snakehead 1 and 2 hours after administration whereas the
same effect occurred 10 min after PGE infusion in non-
anaesthetized dog (Bergstrdm et al., 1966). Similarly,
other metabolic effects of PGE, such as those on plasma
lipid and free fatty acid occurred 1 and 2 hours after
injection. Other reports have shown that the effect of insulin
in fish requires several hours to occur while only a few minutes
is required to elicit the same effect in mammals. This
phenomenon is not only simply explained by the temperature-
related Arrhenius plot and is an intrinsic property of lower
vertebrate biology. It seems that hormonal regulation of
metabolism is less critical in the lower vertebrates which
consequently allows them to better withstand long-lasting
perturbation of the 1 milieu interieur1 (Murat rt al., 1981)•
The assumption of Murat ejt ad. may also explain the present
delayed effects of PGs in snakeheads.
Besides, PGB has been shown to have hypotensive action
in cat (Jones, 1972) but its action in snakehead was hyper¬
tension instead of hypotension. Further, PGF produced
species-dependant cardiovascular effect in mammals (either
hypertension or hypotension). In leopard frog (Rana pipien)
PGF infusion increased arterial pressure whereas PGF0
decreased arterial pressure in bullfrog (Rana catesbiana)
(Leffler et cil., 1980). It is a surprise that PGF in doses
ranging from 5 igkg to 120 yttgkg could not produce any card¬
iovascular effect in snakehead. From the above data, the
different responses of PGs in different classes of animal
may have an evolutionary significance. There is another
example that different response to the same molecule exists
in different groups of animal. Urotensin I( a hormone
secreted from the caudal neurosecretory system of fish)
exerts a uniquely long-lasting depression of systemic blood
pressure in mammals (see Chan and Bern, 1976'; Woo and Bern,
1979) In some amphibian and reptilian species, urotensin I
elicits either hyper- or hypotensive actions while it produces
hypertension in eel (see Chan and Bern, 1976; Woo and Bern,
1979) Therefore, it seems that there is an evolution of
vascular response to urotensins in vertebrates: a hypertensive
t
response in lower vertebrates is gradually succeeded by hypo¬
tensive effects in higher vertebrates® In view of the present
findings, it is likely that a similar evolution of vascular
response to PGs may exist® As comparative studies are extended,
many more deviation from the conventional (mammalian) functional
(
patterns will possibly be revealed. However, there is nof
information on the effect of PGs on cardiovascular system in
reptiles. Also there are very scarce reports on the other
, %
lower vertebrates such as amphibians and fish. Thus it seems
to be premature at the present time to construct an evolutionary
trend of action of PGs in different vertebrate groups.
Nevertheless, these new findings of PGB. and PGF. effects on
1 1 Cs
snakeheads and this will provide more information on the
comparative aspects of physiology.
Although the doses used in present studies were high, j.t
was expected to be a pharmacological dose rather than a
physiological dose. However, only high doses of PGs would
produce observable effects in snakeheads. There was no other
alternative except using a high dose for the present investi¬
gation. Furthermore, the distribution of PGE was demonstrated
in the various tissues of snalcehead and its quantity varied
considerably among different tissues. The ubiquitous presence
of PGE in the snakehead indicates that PGE has a role in the
physiology of this fish. Besides, PG-blockers (aspirin and
indomethacin) were employed in the fish to verify the possible
participation of endogenous PGs in the physiology of snakehead.
Indomethacin treatment significantly lowered the basal arterial
blood pressure and this indicates the actual involvement of
endogenous PGs in normal blood pressure regulation. Also
aspirin treatment lowered plasma Na+ level. It is presumably
that PGs participated in Na+ regulation in snakehead. From
the above evidence, it undoubtedly suggests that PGs do have
physiological functions in snakehead.
According to the original use of the word, hormones are
chemical agents which are synthesized by circumscribed parts
of the body generally specialized, ductless glands and are
carried by the circulatory blood to another part of the body
where they evoke systemic adjustments by acting on specific
tissues and organs (Turner and Bagnara, 197). From this
definition of hormone, PGs seem not to fulfil the above criteria
as a hormone. Since PGEs and PGFs do not survive a single
passage through the lung so that a role for PGs as circulating
hormones seems excluded. Notwithstanding, there is general
acceptance of the fact that PGE is produced in the medulla
of the kidney to regulate the haemodynamics of the cortex
(Herbaczynska-Cedro and Vane, 1973). PGF has been shown to
be the agent, formed in the uterus to shut off progesterone
production in the corpus luteum (luteolysiPGF) (McCracken
et al., 1973) Thus it is clear that PGEs and PGFcs function
as local hormonal regulators and this may be their primary
function. Since PGs are produced in all tissues so far examined
which in turn have the ability to respond to PG action, it
seeins that these mediators may function as intracellular
regulators in many instances.
In addition, there is ample evidence to demonstrate
the relationship between PGs and cAMP, Numerous reports showed
that many hormonal effects are mediated by a sequence of
synthesis of two mediators, PG and cAMP. For example,
urotensin I-induced vasodilatory action is mediated via cAMP
and cGMP formation. An antagonistic interaction between PGs
of the B, E and F series and urotensin I is indicated in
experiments using such PGs and the PG synthetase inhibitor.
The latter substance potentiated the effects of urotensin I
on the, isolated rat tail artery (Lederis and Bern, 1976).
Other hormones, such as LH, stimulate cAMP formation in
isolated mouse ovaries. A PG antagonist blocks the actions
of both PGE and LH in stimulating cAMP formation and it was
suggested that PGs play an essential role in the action of
LH (Kuehl jet al., 1970). Similar observations were made for
the action of other hormones on their target tissues leading
to th$ same conclusion. Finally, in any event, it is reasonable
to predict that PGs will prove to be related to cyclic nucleo¬
tide in some manner. Therefore the PG effects in snakehead
is also expected to mediate via cAMP formation.
In addition, PGE has higher metabolic potency than PGA 9
PGB.J and PGF in snakeheads. These four types of PG uniformly
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elevated plasma glucose in this fish and this effect is
generally true in mammals. PGE1 was also shown to decrease.
plasma protein, lipid, free fatty acid and oxygen consumption.
However, the exact mechanism. of these effects remains unknown
further investigations are required.
Further studies along the lines set out in this thesis
on sub-mammalian vertebrates may prove to be interesting for
those involved in the comparative and evolutionary aspects
of prostaglandin actions.
To recapitulate the major findings in this thesis, the
presence of prostaglandins in the various tissues was clearly
established and endogenous PGs were shown to exert physiological
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